{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":218,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":218,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"0d39423ffff8","filters":{"venue":"Transplantation and Cellular Therapy"}},"results":[{"id":"W4281263083","doi":"10.1016/j.jtct.2022.05.026","title":"Real-World Evidence of Axicabtagene Ciloleucel for the Treatment of Large B Cell Lymphoma in the United States","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Legend Biotech; Pharmacyclics; Kite Pharma; MorphoSys; Daiichi-Sankyo; Miltenyi Biotec; Omeros Corporation; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; TG Therapeutics; bluebird bio; Tessa Therapeutics; BeiGene; Atara Biotherapeutics; Kyowa Kirin Pharmaceutical Development; Janssen Pharmaceuticals; Memorial Sloan-Kettering Cancer Center; National Cancer Institute; Servier; Gilead Sciences; Celgene; Novartis; AbbVie; Merck; Bristol-Myers Squibb; Cidara Therapeutics; AstraZeneca; Amgen; Seagen; Sierra Oncology; Astellas Pharma US","keywords":"Medicine; Internal medicine; Cohort; Odds ratio; Confidence interval; Oncology","retraction":null,"screen_n_in":null,"score":{"opus":0.05882848758754067,"gpt":0.3396543056612309,"spread":0.2808258180736902,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006137591,0.0001058828,0.0001976301,0.0001630675,0.0001243922,0.000007386258,0.0001231793,0.00002067479,0.0003943386],"category_scores_gemma":[0.000001429399,0.00006169817,0.00009783136,0.0004278326,0.00006778174,0.00002214508,0.00000335201,0.00005628006,3.783971e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004799736,"about_ca_system_score_gemma":0.00006071987,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001047316,"about_ca_topic_score_gemma":0.0001379859,"domain_scores_codex":[0.9988875,0.0002291049,0.0002534147,0.0001462478,0.0003192033,0.0001645099],"domain_scores_gemma":[0.9989154,0.0006967001,0.00007646206,0.0002340835,0.00004838688,0.00002894529],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01738753,0.003858186,0.006752062,0.0005309372,0.000233738,0.0000571446,0.06200947,0.0004012965,0.873351,0.000674514,0.00007704879,0.03466701],"study_design_scores_gemma":[0.02721222,0.006410724,0.01661479,0.00008607385,0.0002203134,0.00002085256,0.008475118,0.005289832,0.8844706,0.0001863294,0.05082924,0.0001839121],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992597,0.004622106,0.0005104959,0.0007713343,0.0000294247,0.001190404,0.00009518535,0.000008150902,0.0001758538],"genre_scores_gemma":[0.9183747,0.07974514,0.00003841231,0.0002265677,0.00001897031,0.0002060954,0.0002244186,0.00001455786,0.001151092],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07512303,"threshold_uncertainty_score":0.4317731,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3147838034","doi":"10.1016/j.jtct.2021.03.033","title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":167,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"British Columbia Children's Hospital; CancerCare Manitoba; University of Manitoba","funders":"National Institute of Dental and Craniofacial Research; National Cancer Institute; AbbVie; University at Buffalo; Janssen Pharmaceuticals; Memorial Sloan-Kettering Cancer Center; American Society for Transplantation and Cellular Therapy; National Institutes of Health; Alvin J. Siteman Cancer Center; Universidad de Sevilla; Anthony Nolan; Huntsman Cancer Institute; Takeda Pharmaceuticals U.S.A.; University of Minnesota; Massachusetts General Hospital; Novartis; Celgene; Universität Hamburg; Bristol-Myers Squibb; AstraZeneca; CareDx; Government of South Australia; Dana-Farber Cancer Institute; Pfizer; Amgen; U.S. Department of Veterans Affairs","keywords":"Medicine; Clinical trial; Intensive care medicine; Disease; Standardization; Graft-versus-host disease; Clinical Practice; Consensus conference; MEDLINE; Chronic disease; Pathology; Physical therapy; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.3148686311107944,"gpt":0.5038273522807666,"spread":0.1889587211699722,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007088631,0.0001612691,0.0006098811,0.00008714008,0.0001256993,0.00003131519,0.0000395607,0.00008813231,0.00002572039],"category_scores_gemma":[0.0001847929,0.0001246058,0.0001425897,0.0001615432,0.0001117493,0.0000421695,0.000003884809,0.0001433642,5.922684e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006210396,"about_ca_system_score_gemma":0.001063572,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003784924,"about_ca_topic_score_gemma":0.0001252272,"domain_scores_codex":[0.9959751,0.001140573,0.001969557,0.0003972557,0.0003426355,0.0001748409],"domain_scores_gemma":[0.9964864,0.002721028,0.0004590643,0.0001241421,0.0001138099,0.00009556729],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02182084,0.001442409,0.7281646,0.003276748,0.001131334,0.0006411547,0.01134434,0.000007404871,0.006535163,0.001962313,0.000745095,0.2229286],"study_design_scores_gemma":[0.02857203,0.001235305,0.9469835,0.00112543,0.0002596545,0.00008684525,0.0008565295,0.0001154954,0.0106311,0.0000821936,0.009786647,0.000265336],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9891837,0.003897221,0.002373867,0.002041951,0.0003962171,0.001992645,0.0000579563,0.00001880228,0.00003763175],"genre_scores_gemma":[0.9680322,0.02841015,0.001839945,0.0003282878,0.0001818552,0.0002743137,0.0009018867,0.00001833845,0.00001301795],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2226633,"threshold_uncertainty_score":0.5081276,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3170028153","doi":"10.1016/j.jtct.2021.06.001","title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"British Columbia Children's Hospital; CancerCare Manitoba; University of Manitoba","funders":"National Eye Institute; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Medicine; Clinical trial; Disease; Intensive care medicine; Graft-versus-host disease; Quality of life (healthcare); Clinical endpoint; Immunology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.2216126711212622,"gpt":0.4578937357769836,"spread":0.2362810646557214,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004182446,0.0001608216,0.0005660415,0.00008566218,0.0001006487,0.00001803565,0.00004819818,0.00007971702,0.00003095364],"category_scores_gemma":[0.0001723031,0.0001120882,0.0001499535,0.00016695,0.00008799927,0.00003670052,0.000002290249,0.0001192278,0.000001864712],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008593811,"about_ca_system_score_gemma":0.002267068,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001761547,"about_ca_topic_score_gemma":0.00004614591,"domain_scores_codex":[0.9971378,0.0005295625,0.001450454,0.0003216442,0.0003835104,0.0001769769],"domain_scores_gemma":[0.9980867,0.001189729,0.0003315431,0.0001524528,0.0001560461,0.00008352868],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.2024914,0.009085083,0.06511857,0.03809467,0.006062887,0.007248202,0.05160649,0.0003809028,0.4050617,0.04222428,0.006809901,0.1658159],"study_design_scores_gemma":[0.1282234,0.004120118,0.3505273,0.005098018,0.0008264158,0.0009802609,0.001983654,0.00243885,0.4307746,0.0009693364,0.07273044,0.001327553],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9836248,0.003355929,0.005433612,0.004195125,0.0004882994,0.002400113,0.0001406174,0.000031832,0.0003297073],"genre_scores_gemma":[0.9845467,0.01105951,0.001655326,0.000492433,0.0001433298,0.0001808583,0.001779578,0.0000218603,0.0001204388],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2854087,"threshold_uncertainty_score":0.4570826,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4400094794","doi":"10.1016/j.jtct.2024.06.021","title":"Current Trends and Outcomes in Cellular Therapy Activity in the United States, Including Prospective Patient-Reported Outcomes Data Collection in the Center for International Blood and Marrow Transplant Research Registry","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; MorphoSys; Seagen; Swedish Orphan Biovitrum; Omeros Corporation; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; Medac; Jazz Pharmaceuticals; BeiGene; HistoGenetics; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Sanofi; GlaxoSmithKline; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Gateway for Cancer Research; Alexion Pharmaceuticals; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Amgen; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation","keywords":"Medicine; Data collection; Family medicine; Statistics","retraction":null,"screen_n_in":null,"score":{"opus":0.1070718053539612,"gpt":0.3926015508572358,"spread":0.2855297455032746,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001662284,0.0001484494,0.0001968711,0.000501974,0.0001212657,0.00009593627,0.0001155424,0.0001167029,0.000006962171],"category_scores_gemma":[0.00001705923,0.00008257465,0.00003283157,0.0005700876,0.0002149666,0.000127826,0.000009619276,0.0005171712,7.78385e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003211558,"about_ca_system_score_gemma":0.00004576335,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004267639,"about_ca_topic_score_gemma":0.0004362376,"domain_scores_codex":[0.998381,0.0003184103,0.0003121617,0.000366277,0.0004393926,0.000182793],"domain_scores_gemma":[0.9992437,0.0004191441,0.00005012699,0.0001808346,0.00006834957,0.00003778071],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00464616,0.002173079,0.6927004,0.0007125183,0.0004393911,0.0003271529,0.1070682,0.000008409957,0.02067056,0.001471504,0.00009811315,0.1696846],"study_design_scores_gemma":[0.01674289,0.0007138337,0.9468377,0.0006424324,0.0001009001,0.00009056984,0.002570158,0.01856344,0.004246286,0.002149177,0.007051405,0.0002911511],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9853495,0.00210306,0.0006002804,0.01069045,0.0001764893,0.0009165935,0.0001167047,0.00001456873,0.00003234793],"genre_scores_gemma":[0.976904,0.02116903,0.0000324349,0.000178262,0.00003321263,0.00009595111,0.001546696,0.00001267595,0.00002774699],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2541374,"threshold_uncertainty_score":0.3367296,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4281695451","doi":"10.1016/j.jtct.2022.05.038","title":"Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force","year":2022,"lang":"en","type":"review","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; University of Manitoba; BC Children's Hospital; CancerCare Manitoba","funders":"National Cancer Institute; Deutsche Forschungsgemeinschaft; National Institutes of Health; Memorial Sloan-Kettering Cancer Center","keywords":"Medicine; Disease; Graft-versus-host disease; Immunology; Hematopoietic stem cell transplantation; Chronic disease; Intensive care medicine; Immune system; Pathogenesis; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.1264042649032465,"gpt":0.3464650355770398,"spread":0.2200607706737933,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005223991,0.0002623351,0.0009250669,0.00008691131,0.0001272,0.000008754082,0.0001609123,0.0001142057,0.00007635704],"category_scores_gemma":[0.00002420305,0.0001563375,0.0003880499,0.0003150126,0.000282374,0.00002482546,0.000009855362,0.0003038323,3.109494e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001564401,"about_ca_system_score_gemma":0.001670091,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001299368,"about_ca_topic_score_gemma":0.00002437899,"domain_scores_codex":[0.9973926,0.0004493332,0.0009530612,0.0003110972,0.000740459,0.0001534514],"domain_scores_gemma":[0.9980565,0.0007799796,0.0007772741,0.0002761643,0.00005664679,0.00005343638],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.03130231,0.002965468,0.004587521,0.4786219,0.01711399,0.001717936,0.06042994,0.00006065811,0.007399194,0.02539039,0.004559943,0.3658508],"study_design_scores_gemma":[0.04092457,0.00308088,0.01170828,0.09673706,0.01721915,0.003419434,0.004699502,0.0002110537,0.005669994,0.002217898,0.8117471,0.002365022],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002660305,0.9907502,0.001641698,0.0008551065,0.0003451488,0.002407912,0.001091543,0.00001809011,0.0002299798],"genre_scores_gemma":[0.04075948,0.9568895,0.00009332002,0.0000962778,0.00008627572,0.00007188274,0.001932177,0.00003122167,0.00003983561],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8071872,"threshold_uncertainty_score":0.6375257,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4392165940","doi":"10.1016/j.jtct.2023.12.001","title":"International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update","year":2024,"lang":"en","type":"review","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Children's Hospital; Dalhousie University; University of Calgary; University of Saskatchewan","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; University of Texas MD Anderson Cancer Center; National Heart, Lung, and Blood Institute; Office of Naval Research; National Center for Advancing Translational Sciences; Health Resources and Services Administration; Gateway for Cancer Research; Patient-Centered Outcomes Research Institute; Nagoya City University; University of Pennsylvania; National Institute of Environmental Health Sciences; Memorial Sloan-Kettering Cancer Center","keywords":"Medicine; Survivorship curve; Transplantation; Hematopoietic cell; Intensive care medicine; Disease; MEDLINE; Family medicine; Pediatrics; Stem cell; Cancer; Internal medicine; Haematopoiesis","retraction":null,"screen_n_in":null,"score":{"opus":0.1055153482783449,"gpt":0.3960425183423122,"spread":0.2905271700639672,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007090823,0.0005276496,0.001092143,0.0004318067,0.0001487907,0.000108098,0.000114273,0.0003183926,0.00007110035],"category_scores_gemma":[0.00001165535,0.0004427851,0.0003099045,0.0002041236,0.0001240457,0.0002711637,0.000005897707,0.0002539515,0.000002454899],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002504023,"about_ca_system_score_gemma":0.0001115583,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004660712,"about_ca_topic_score_gemma":0.00003579097,"domain_scores_codex":[0.997574,0.0002188144,0.0009641738,0.0006970899,0.0002883342,0.0002575353],"domain_scores_gemma":[0.9979845,0.0008070073,0.0007411767,0.000172267,0.0001563562,0.0001387109],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002152886,0.0002141059,0.0002320079,0.07641886,0.002303142,0.00005222388,0.006490113,6.947444e-7,0.002336204,0.0006245161,0.00004882421,0.9091264],"study_design_scores_gemma":[0.04145695,0.003855253,0.0008461742,0.07734974,0.03316402,0.002300901,0.002163208,0.001013589,0.03406675,0.001003873,0.7992837,0.003495788],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.006267881,0.8892534,0.09603792,0.000595186,0.0003962629,0.005097493,0.002159697,0.00006757259,0.000124546],"genre_scores_gemma":[0.001726892,0.9808435,0.004967198,0.000072443,0.0001376257,0.0006630208,0.01112713,0.00010895,0.0003532431],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9056306,"threshold_uncertainty_score":0.9998024,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3171632039","doi":"10.1016/j.jtct.2021.05.004","title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Children's Hospital","funders":"National Institutes of Health; Sapienza Università di Roma; CTI Biopharma; Meiji Seika Pharma; Dana-Farber Cancer Institute; Pfizer; CareDx; Government of South Australia; Janssen Pharmaceuticals; Gilead Sciences; Massachusetts General Hospital; Bristol-Myers Squibb; AstraZeneca; Novartis; Amgen; National Cancer Institute; Takeda Pharmaceutical Company","keywords":"Medicine; Clinical trial; Intensive care medicine; Disease; Context (archaeology); Graft-versus-host disease; Systemic therapy; Chronic disease; Internal medicine; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.2395835741235416,"gpt":0.4655049099569021,"spread":0.2259213358333605,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002268956,0.0001580045,0.0006663429,0.00008178609,0.00006790298,0.000008402855,0.00003583829,0.00006956967,0.00005772425],"category_scores_gemma":[0.00007381938,0.0001103706,0.0001703251,0.0001472061,0.0001005595,0.0000215004,0.000001391336,0.00005990404,8.171411e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001926941,"about_ca_system_score_gemma":0.003389374,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003403631,"about_ca_topic_score_gemma":0.00007499225,"domain_scores_codex":[0.9972236,0.0005610447,0.001466425,0.0002891423,0.0003099222,0.0001498715],"domain_scores_gemma":[0.9981017,0.001148209,0.0003897884,0.0001536212,0.0001412512,0.00006540262],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.1283776,0.01512547,0.03229736,0.02633397,0.006709159,0.003488276,0.05121304,0.0004678952,0.326156,0.01224395,0.001268561,0.3963187],"study_design_scores_gemma":[0.1249931,0.00810239,0.1636586,0.002360011,0.0008143213,0.0003630706,0.001077063,0.001508914,0.6676159,0.000162745,0.02869004,0.0006538443],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9818199,0.009893427,0.002991881,0.001775416,0.0004445038,0.002715561,0.0001514545,0.00001923598,0.0001886767],"genre_scores_gemma":[0.9721143,0.02519302,0.0008269421,0.00009362882,0.0001327191,0.0001785802,0.001341392,0.00001666904,0.0001027933],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3956649,"threshold_uncertainty_score":0.6012603,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4313252429","doi":"10.1016/j.jtct.2022.12.017","title":"Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Kite Pharma; Sanofi Genzyme; Takeda Oncology; Health Resources and Services Administration; MorphoSys; Omeros Corporation; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; TG Therapeutics; StemCyte; Actinium Pharmaceuticals; CareDx; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; HistoGenetics; Atara Biotherapeutics; Daiichi Sankyo Europe; National Cancer Institute; Gilead Sciences; Sanofi; GlaxoSmithKline; Mallinckrodt Pharmaceuticals; Astellas Pharma US; CSL Behring; Eli Lilly and Company; Bristol-Myers Squibb; Amgen; Medac; Jazz Pharmaceuticals; Be The Match Foundation","keywords":"Medicine; Cyclophosphamide; Internal medicine; Transplantation; Incidence (geometry); Bone marrow; Clinical trial; Prospective cohort study; Clinical endpoint; Surgery; Hematopoietic stem cell transplantation; Hematopoietic cell; Gastroenterology; Oncology; Chemotherapy; Haematopoiesis; Stem cell","retraction":null,"screen_n_in":null,"score":{"opus":0.04516008171446839,"gpt":0.3226275748341489,"spread":0.2774674931196805,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001251233,0.0004694568,0.001036567,0.0004371085,0.0002167356,0.0000365099,0.00018074,0.0003082656,0.0004097007],"category_scores_gemma":[0.00002472674,0.0004577478,0.0003617809,0.0005858195,0.0001602439,0.0002209236,0.000008356725,0.0005915781,0.000007186475],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001635589,"about_ca_system_score_gemma":0.0003430145,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007124218,"about_ca_topic_score_gemma":0.0003313886,"domain_scores_codex":[0.9953656,0.0005354672,0.001682929,0.0008143039,0.001160922,0.0004407678],"domain_scores_gemma":[0.9983123,0.0005346641,0.0004404108,0.0002703781,0.0002348918,0.0002073844],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3177208,0.003165708,0.51445,0.0005547054,0.0008722571,0.0005435695,0.0121213,0.0001565436,0.147358,0.0002617717,0.000007387688,0.002788014],"study_design_scores_gemma":[0.3395593,0.004607268,0.5946144,0.0007032659,0.001225908,0.000257772,0.001364158,0.002256315,0.05311251,0.001197195,0.00006219814,0.001039741],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904444,0.0004110203,0.002335218,0.0001845365,0.0007488838,0.004341577,0.001249231,0.0001305918,0.0001544968],"genre_scores_gemma":[0.9909803,0.001879364,0.003045477,0.0001574869,0.00006715725,0.0003991918,0.00330721,0.00008145444,0.00008237516],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09424544,"threshold_uncertainty_score":0.9997874,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3135738459","doi":"10.1016/j.jtct.2021.02.035","title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report","year":2021,"lang":"en","type":"review","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Children's Hospital","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Medicine; Graft-versus-host disease; Intensive care medicine; Disease; Etiology; Transplantation; Clinical trial; Immune system; Immunology; Intervention (counseling); Chronic disease; Internal medicine; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.410621616559488,"gpt":0.520370479022987,"spread":0.1097488624634991,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00740356,0.0002785143,0.00176137,0.000167104,0.0001035357,0.00002160412,0.00005559549,0.0002162459,0.0000158721],"category_scores_gemma":[0.0001744637,0.0001948825,0.0003036959,0.0001809865,0.0001236946,0.00002181305,0.00000403695,0.0002315875,6.012117e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001114713,"about_ca_system_score_gemma":0.002281276,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000103189,"about_ca_topic_score_gemma":0.00003435066,"domain_scores_codex":[0.9945863,0.002136695,0.002324564,0.0004872971,0.0002843238,0.0001808312],"domain_scores_gemma":[0.9963307,0.00248645,0.0008806572,0.0001501779,0.000078643,0.00007331237],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003355711,0.000352411,0.0002115594,0.04206785,0.0009477411,0.0002261731,0.001224596,0.000001384072,0.0001024839,0.001466901,0.0001233807,0.9499198],"study_design_scores_gemma":[0.02537208,0.002013016,0.003501739,0.0750901,0.002319482,0.0008386042,0.0002482502,0.0001010913,0.0001985098,0.0001575074,0.8893598,0.0007998573],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00341722,0.9876136,0.003422851,0.0003104756,0.0004852322,0.004601629,0.00007759508,0.0000191113,0.00005231709],"genre_scores_gemma":[0.001974039,0.9918996,0.001360569,0.00006764833,0.0001820862,0.0004243642,0.004024727,0.00002814124,0.00003879246],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9491199,"threshold_uncertainty_score":0.7947079,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3175898740","doi":"10.1016/j.jtct.2021.06.029","title":"Prophylactic or Preemptive Low-Dose Azacitidine and Donor Lymphocyte Infusion to Prevent Disease Relapse following Allogeneic Transplantation in Patients with High-Risk Acute Myelogenous Leukemia or Myelodysplastic Syndrome","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hotel Dieu Hospital","funders":"Centre Hospitalier Universitaire de Nantes","keywords":"Medicine; Donor lymphocyte infusion; Transplantation; Cumulative incidence; Internal medicine; Azacitidine; Myelodysplastic syndromes; Hematopoietic stem cell transplantation; Chronic myelogenous leukemia; Leukemia; Oncology; Surgery; Bone marrow","retraction":null,"screen_n_in":null,"score":{"opus":0.008411363278042653,"gpt":0.234448961935023,"spread":0.2260375986569804,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002241824,0.0003985446,0.0005070764,0.0002973007,0.0002035461,0.00006177158,0.00009259344,0.0001475072,0.00008656638],"category_scores_gemma":[0.00003540187,0.0002795543,0.00007309304,0.0005711916,0.00007663669,0.0002580734,0.00001649817,0.0002943211,0.00001436059],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004188075,"about_ca_system_score_gemma":0.0009509473,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001404337,"about_ca_topic_score_gemma":0.0001774646,"domain_scores_codex":[0.9975445,0.0002829486,0.0004239491,0.0007228287,0.0005656251,0.0004601518],"domain_scores_gemma":[0.998799,0.0001621554,0.0001113368,0.0002838729,0.0001639431,0.0004796372],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4213549,0.003185901,0.2544094,0.005837455,0.002029575,0.06285658,0.02436931,0.001362794,0.1763434,0.0000477623,0.00001551912,0.04818742],"study_design_scores_gemma":[0.04712683,0.005568502,0.8993886,0.001140316,0.00144588,0.0005620267,0.0002516556,0.0003576704,0.04335193,0.00002885373,0.00004887984,0.0007288874],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952191,0.0004491427,0.001605939,0.0001487238,0.0001018283,0.002209409,0.0001977084,0.00005654442,0.00001167856],"genre_scores_gemma":[0.9881856,0.008533986,0.001062292,0.0002673068,0.00003185888,0.0001994981,0.001052336,0.00007191906,0.0005951888],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6449792,"threshold_uncertainty_score":0.9999657,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3146762921","doi":"10.1016/j.jtct.2021.03.029","title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; British Columbia Children's Hospital; CancerCare Manitoba","funders":"Pharmacyclics; Universität Hamburg; Meiji Seika Pharma; Compass Therapeutics; Syndax Pharmaceuticals; CTI Biopharma; Alvin J. Siteman Cancer Center; Jazz Pharmaceuticals; National Institutes of Health; Regeneron Pharmaceuticals; Omeros Corporation; Anthony Nolan; Huntsman Cancer Institute; Takeda Pharmaceuticals U.S.A.; Massachusetts General Hospital; University of Minnesota; Janssen Pharmaceuticals; Memorial Sloan-Kettering Cancer Center; University at Buffalo; AbbVie; Clinical Science Research and Development; Universidad de Sevilla; National Cancer Institute; Gilead Sciences; Dana-Farber Cancer Institute; Roche; Novartis; Celgene; Bristol-Myers Squibb; AstraZeneca; CareDx; Incyte; Pfizer; Amgen; U.S. Department of Veterans Affairs","keywords":"Medicine; Graft-versus-host disease; Intensive care medicine; Clinical trial; Disease; Hematopoietic stem cell transplantation; Hematopoietic cell; Psychological intervention; Transplantation; Malignancy; Immunology; Internal medicine; Haematopoiesis; Stem cell","retraction":null,"screen_n_in":null,"score":{"opus":0.2873942891593231,"gpt":0.4623925765223438,"spread":0.1749982873630206,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00509806,0.000192588,0.0006206165,0.00009469411,0.0001288654,0.00002392352,0.00005760047,0.00009188538,0.00003453585],"category_scores_gemma":[0.0001691158,0.0001392794,0.0001704601,0.0002069989,0.0001091212,0.00003439904,0.000002625849,0.0001530229,0.000001116464],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009539304,"about_ca_system_score_gemma":0.001697687,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001779515,"about_ca_topic_score_gemma":0.00004988564,"domain_scores_codex":[0.996529,0.001025453,0.001439218,0.0003955562,0.0004134999,0.0001972165],"domain_scores_gemma":[0.9972702,0.001850534,0.0004936234,0.0001607661,0.0001447673,0.00008012767],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.2121216,0.007137903,0.1022291,0.01053894,0.005365645,0.003418923,0.06595068,0.0001619696,0.2359987,0.01476954,0.001801308,0.3405056],"study_design_scores_gemma":[0.1395064,0.004901284,0.5639795,0.006964775,0.0005292071,0.0006018757,0.002650327,0.001726649,0.2239483,0.0006788389,0.0531664,0.001346459],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9766769,0.008733793,0.007667392,0.002525303,0.0005899548,0.003401613,0.00008047879,0.00003803555,0.000286521],"genre_scores_gemma":[0.9702622,0.02527855,0.002151715,0.0004879233,0.0002054972,0.0002579637,0.001261853,0.0000265472,0.0000677524],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4617504,"threshold_uncertainty_score":0.567965,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4383226811","doi":"10.1016/j.jtct.2023.06.012","title":"ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Diffuse Large B Cell Lymphoma","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Transplantation; ThioTEPA; Oncology; Lymphoma; Rituximab; Hematopoietic cell; Chimeric antigen receptor; Salvage therapy; Internal medicine; CHOP; Chemotherapy; Cancer; Haematopoiesis; Immunotherapy; Stem cell; Cyclophosphamide","retraction":null,"screen_n_in":null,"score":{"opus":0.06321421224880473,"gpt":0.3757907171074914,"spread":0.3125765048586867,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001530122,0.0002466005,0.0003800018,0.000325804,0.0001963615,0.00007075508,0.00008445956,0.000202125,0.0001965152],"category_scores_gemma":[0.00002182349,0.0002271854,0.0001308158,0.0003989276,0.00009683022,0.0002479257,0.000006030275,0.000220396,0.00002101053],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003012538,"about_ca_system_score_gemma":0.00007862707,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005434518,"about_ca_topic_score_gemma":0.00004518573,"domain_scores_codex":[0.9978411,0.0003581363,0.0005820601,0.0004880246,0.0003144664,0.0004161794],"domain_scores_gemma":[0.9984254,0.0009630198,0.0001093262,0.0002211847,0.0001056821,0.0001753465],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.02089052,0.007194937,0.01272642,0.001608063,0.0005128767,0.0006491985,0.04006014,0.000005713501,0.5521014,0.00172417,0.000827255,0.3616993],"study_design_scores_gemma":[0.2511944,0.004154929,0.05333885,0.0005261868,0.0007803914,0.0003618801,0.01176606,0.006006455,0.2709965,0.001654077,0.3976701,0.001550146],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9825807,0.002060643,0.008002174,0.004562314,0.0001880672,0.001487917,0.0001486398,0.000136216,0.0008333629],"genre_scores_gemma":[0.8762243,0.1171037,0.001638671,0.001101288,0.0001549958,0.0001895841,0.001608853,0.00007482001,0.001903816],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3968428,"threshold_uncertainty_score":0.9264351,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3143839826","doi":"10.1016/j.jtct.2021.03.024","title":"Home Spirometry Telemonitoring for Early Detection of Bronchiolitis Obliterans Syndrome in Patients with Chronic Graft-versus-Host Disease","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"National Cancer Institute; National Institutes of Health; National Cancer Center","keywords":"Spirometry; Medicine; Bronchiolitis obliterans; Interquartile range; Spirometer; Cohort; Pulmonary function testing; Internal medicine; Physical therapy; Lung transplantation; Asthma; Transplantation; Exhaled nitric oxide","retraction":null,"screen_n_in":null,"score":{"opus":0.01362379392308099,"gpt":0.2562404542175535,"spread":0.2426166602944725,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009370627,0.0001501213,0.0002678271,0.0001633905,0.00005438787,0.00001816794,0.00003215856,0.00006084954,0.00001866414],"category_scores_gemma":[0.000003257995,0.0001294342,0.00007998542,0.0002532373,0.00003784605,0.0001332796,0.000001255053,0.00009440382,6.029964e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003529499,"about_ca_system_score_gemma":0.00005903178,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003734554,"about_ca_topic_score_gemma":0.00003762035,"domain_scores_codex":[0.9990487,0.000060184,0.0002630772,0.0002445648,0.0002027648,0.0001807434],"domain_scores_gemma":[0.9995106,0.0001075372,0.0000612268,0.0001267005,0.00008558822,0.0001082955],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009453652,0.000275769,0.9167302,0.0014697,0.0001695083,0.0001485876,0.001284529,0.000009995261,0.04686807,0.0001356339,7.784061e-8,0.02345427],"study_design_scores_gemma":[0.01778528,0.0009200092,0.9348096,0.0002630639,0.0001479997,0.00001188507,0.00003774737,0.00001752532,0.04578628,0.0000328495,0.00004156245,0.0001462063],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9766794,0.001264713,0.02116483,0.00004655812,0.0001822839,0.0005061461,0.0001149176,0.00002437823,0.00001670413],"genre_scores_gemma":[0.9966166,0.001451002,0.001469264,0.00002719047,0.00004100585,0.0000337007,0.0002969756,0.00002517421,0.00003910812],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02330807,"threshold_uncertainty_score":0.5278175,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3206827112","doi":"10.1016/j.jtct.2021.10.008","title":"Bloodstream Infections and Outcomes Following Allogeneic Hematopoietic Cell Transplantation: A Single-Center Study","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Transplantation; Hazard ratio; Internal medicine; Univariate analysis; Hematopoietic stem cell transplantation; Incidence (geometry); Single Center; Graft-versus-host disease; Surgery; Multivariate analysis; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.02174963218666461,"gpt":0.2650072341283943,"spread":0.2432576019417297,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000184964,0.000316264,0.0004597865,0.0001459482,0.0002081151,0.00007945488,0.00004549564,0.0001287908,0.000146438],"category_scores_gemma":[0.000003342677,0.0002900178,0.0001618424,0.0002364052,0.00005313397,0.0001408589,0.000004276259,0.0001696326,0.00001434658],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001926129,"about_ca_system_score_gemma":0.00006246192,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002781813,"about_ca_topic_score_gemma":0.00006826309,"domain_scores_codex":[0.9982247,0.0001729346,0.0004703745,0.0005058239,0.0003513148,0.0002748155],"domain_scores_gemma":[0.9992693,0.0001534811,0.0000746112,0.000234137,0.00007022374,0.0001982439],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001572338,0.00247563,0.8353459,0.0007098643,0.0003516215,0.001498879,0.01240774,0.000004559481,0.1454122,0.00006725048,0.000003347999,0.001565802],"study_design_scores_gemma":[0.04298684,0.001975473,0.4713854,0.0005302569,0.002744185,0.004297462,0.00764838,0.00003202754,0.4667701,0.0001508263,0.0004171062,0.001062001],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911426,0.001145774,0.004753379,0.0002957608,0.0001761321,0.0008703124,0.00003190675,0.0001099253,0.00147418],"genre_scores_gemma":[0.9951397,0.002958826,0.0006401308,0.0003732484,0.0000275041,0.0000718064,0.0003277391,0.00004617311,0.0004148698],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3639605,"threshold_uncertainty_score":0.9999552,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4288753092","doi":"10.1016/j.jtct.2022.07.024","title":"Safety and Immunogenicity After a Three-Dose SARS-CoV-2 Vaccine Schedule in Allogeneic Stem Cell Transplant Recipients","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Toronto; Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre; University of British Columbia; University Health Network","funders":"Public Health Agency of Canada","keywords":"Medicine; Immunogenicity; Interquartile range; CD8; Immunology; Vaccination; Internal medicine; Stem cell; Antibody; Gastroenterology; Antigen; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.02887719323573865,"gpt":0.2870834655666574,"spread":0.2582062723309188,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005075206,0.0002484086,0.0003600975,0.0002409954,0.0001831497,0.00002851539,0.000122457,0.00009579793,0.0000497596],"category_scores_gemma":[6.597836e-7,0.0002265967,0.00009819419,0.0003117328,0.00004979328,0.00009338518,0.00001863053,0.0003939795,0.000008168027],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007245805,"about_ca_system_score_gemma":0.00008599965,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002385859,"about_ca_topic_score_gemma":0.0002793668,"domain_scores_codex":[0.9981601,0.0001914032,0.0004120482,0.0004623659,0.0004122259,0.0003619092],"domain_scores_gemma":[0.9995655,0.0000558414,0.00005856161,0.0002424023,0.00003295996,0.00004468162],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01810149,0.0003745599,0.1345256,0.0001521571,0.00007852082,0.0004843591,0.003560383,0.000002436371,0.8350068,0.00002205431,0.000002709284,0.007688885],"study_design_scores_gemma":[0.0186467,0.0008536345,0.1006421,0.00007824151,0.00009643676,0.0002352055,0.0002377862,0.0006034573,0.8705382,0.00006511117,0.007640692,0.0003624612],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895307,0.00833689,0.0007562248,0.0001889161,0.00008132368,0.0007763474,0.00008995076,0.00004363274,0.0001960179],"genre_scores_gemma":[0.9917726,0.0018773,0.00005753944,0.006003844,0.00002518282,0.0001324255,0.00006604572,0.00003793093,0.00002715715],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03553131,"threshold_uncertainty_score":0.9240345,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3201321334","doi":"10.1016/j.jtct.2021.09.009","title":"Haploidentical Allogeneic Stem Cell Transplantation in Sickle Cell Disease: A Systematic Review and Meta-Analysis","year":2021,"lang":"en","type":"review","venue":"Transplantation and Cellular Therapy","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Academisch Medisch Centrum","keywords":"Medicine; Meta-analysis; Transplantation; Internal medicine; Odds ratio; Hematopoietic stem cell transplantation; Subgroup analysis; Oncology; Sibling; Cyclophosphamide; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.04194712540333671,"gpt":0.2970603399105952,"spread":0.2551132145072585,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004749633,0.0005708996,0.005098327,0.0003625301,0.00007577315,0.00005717595,0.0000980074,0.0003100785,0.0002506866],"category_scores_gemma":[0.000002087336,0.0003887318,0.001602097,0.0007546195,0.0000629674,0.00006919013,0.000005392545,0.0003754109,0.0000143185],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002935326,"about_ca_system_score_gemma":0.0001384614,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001717104,"about_ca_topic_score_gemma":0.00001165867,"domain_scores_codex":[0.9967487,0.0007443714,0.001202897,0.0006568903,0.0003671416,0.0002799678],"domain_scores_gemma":[0.9988532,0.0001505814,0.0002969765,0.0003668292,0.00005684428,0.0002755817],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00003455923,0.0002044638,0.000007101974,0.9773974,0.0192866,0.0006992063,0.0004204527,0.000002543559,0.00001260229,0.00002844724,0.000005266576,0.001901372],"study_design_scores_gemma":[0.001143858,0.00006481618,0.000007852594,0.0317785,0.9627982,0.0001326237,0.00009502431,0.00001583654,0.0000399384,0.000003727287,0.003451708,0.0004679462],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001715206,0.9957424,0.0005978469,0.0001345007,0.00002303036,0.003021099,0.0001702715,0.00003475828,0.0001045868],"genre_scores_gemma":[0.0007879531,0.9954715,0.00004110017,0.0004709108,0.000008308734,0.0003406758,0.001761794,0.00005726415,0.001060446],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9456189,"threshold_uncertainty_score":0.9998565,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3134469664","doi":"10.1016/j.jtct.2021.03.006","title":"Myeloablative Busulfan/Melphalan Consolidation following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma: Children's Oncology Group Trial ANBL12P1","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health; Bayer Fund; St. Baldrick's Foundation; Alex's Lemonade Stand Foundation for Childhood Cancer; Novartis; Loxo Oncology; Dougherty Foundation; Roche","keywords":"Medicine; Busulfan; Melphalan; Induction chemotherapy; Surgery; Tolerability; Internal medicine; Chemotherapy; Oncology; Hematopoietic stem cell transplantation; Transplantation; Adverse effect","retraction":null,"screen_n_in":null,"score":{"opus":0.01103418258268558,"gpt":0.2599738957661657,"spread":0.2489397131834801,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012748,0.0002356047,0.0003371191,0.000134617,0.0002173606,0.00005966593,0.00004007858,0.0001229545,0.00005134861],"category_scores_gemma":[0.00001543119,0.0001904392,0.000121341,0.0002341367,0.00006244569,0.0002325786,0.000002825247,0.0001879511,0.000002977836],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005337685,"about_ca_system_score_gemma":0.0001406818,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006562373,"about_ca_topic_score_gemma":0.00003190123,"domain_scores_codex":[0.998463,0.0002369791,0.0002576828,0.0004650807,0.0003026606,0.0002745469],"domain_scores_gemma":[0.9992241,0.0002413875,0.0001065761,0.0001497891,0.0001225006,0.0001556555],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2522723,0.00561714,0.05634051,0.0002014405,0.002800624,0.0009089898,0.003431955,0.00003423693,0.06784925,0.0002882641,0.00009977834,0.6101555],"study_design_scores_gemma":[0.4539547,0.02016933,0.4201929,0.0001491705,0.0005114488,0.00008165852,0.0001552396,0.0001396035,0.1031515,0.0001425168,0.0009267598,0.0004251362],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9884047,0.0001659473,0.00851897,0.0003181785,0.0002115847,0.002160291,0.0001006005,0.00007988052,0.00003984943],"genre_scores_gemma":[0.9928005,0.002652285,0.001209,0.0002170723,0.0001413089,0.0001874168,0.002686126,0.00004869008,0.00005765136],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6097304,"threshold_uncertainty_score":0.7765885,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4290851731","doi":"10.1016/j.jtct.2022.08.010","title":"The Cost-Effectiveness of Axicabtagene Ciloleucel as Second-Line Therapy in Patients with Large B-Cell Lymphoma in the United States: An Economic Evaluation of the ZUMA-7 Trial","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Institutes of Health; Miltenyi Biotec; Kite Pharma; Division of Cancer Prevention, National Cancer Institute; Gilead Sciences; AstraZeneca; Bristol-Myers Squibb; National Cancer Institute; AbbVie; Merck; Roche; Astellas Pharma US; Amgen","keywords":"Medicine; Chemoimmunotherapy; Cost effectiveness; Quality-adjusted life year; Clinical trial; Oncology; Internal medicine; Lymphoma; Rituximab","retraction":null,"screen_n_in":null,"score":{"opus":0.0411253268733812,"gpt":0.3165985277671497,"spread":0.2754732008937685,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00413934,0.0001569622,0.0002541187,0.0001665155,0.0001788785,0.00001915042,0.0002439408,0.00004923771,0.000525059],"category_scores_gemma":[0.000004467726,0.0000850576,0.00007213086,0.0004041223,0.0001141948,0.00006181554,0.000009251326,0.0002014814,6.631718e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001390891,"about_ca_system_score_gemma":0.0002595455,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003387228,"about_ca_topic_score_gemma":0.0002086162,"domain_scores_codex":[0.9958513,0.002616728,0.0003787749,0.0002288528,0.0007161851,0.0002080939],"domain_scores_gemma":[0.9989165,0.0003947678,0.0001637381,0.0003712797,0.0001180223,0.00003571051],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.689983,0.01071733,0.05409516,0.0002796398,0.0004195316,0.00001968227,0.03606736,0.006458394,0.09743915,0.0004905802,0.000009959316,0.1040202],"study_design_scores_gemma":[0.5285041,0.01135789,0.2711124,0.00008337739,0.0001148778,0.00001156524,0.004710353,0.007517975,0.1738357,0.0004442716,0.002014782,0.0002926162],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946718,0.0004372185,0.00002766094,0.00009294539,0.00007764858,0.00439387,0.0001052737,0.000006138076,0.0001874003],"genre_scores_gemma":[0.9971178,0.001556183,0.000002136198,0.0001755667,0.0000165755,0.0003967781,0.0006512914,0.00002461745,0.00005906182],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2170173,"threshold_uncertainty_score":0.5749028,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3151577537","doi":"10.1016/j.jtct.2021.03.028","title":"Breaking the Age Barrier: Physicians’ Perceptions of Candidacy for Allogeneic Hematopoietic Cell Transplantation in Older Adults","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital","funders":"Janssen Pharmaceuticals; National Center for Advancing Translational Sciences; Abbott Laboratories; National Institute on Aging; U.S. Public Health Service; Genentech; Daiichi-Sankyo; Kyowa Kirin Pharmaceutical Development; National Institute of Allergy and Infectious Diseases; Angiocrine Bioscience; Medical College of Wisconsin; Novartis; Merck; GlaxoSmithKline; Takeda Pharmaceuticals U.S.A.; Amgen; National Heart, Lung, and Blood Institute; Pfizer; Health Resources and Services Administration; Astellas Pharma US; Office of Naval Research; Jazz Pharmaceuticals; Intel Corporation; National Cancer Institute; AbbVie; Sanofi","keywords":"Candidacy; Medicine; Hematopoietic cell; Transplantation; Young adult; Regimen; Family medicine; Gerontology; Internal medicine; Stem cell; Haematopoiesis","retraction":null,"screen_n_in":null,"score":{"opus":0.03162625551612509,"gpt":0.3247208810890929,"spread":0.2930946255729678,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009441397,0.0001085867,0.0002327243,0.00005640139,0.00004947992,0.000006385682,0.00003990488,0.00005807027,0.00005259111],"category_scores_gemma":[0.000002580201,0.00008532405,0.0001042771,0.0001347232,0.00006063209,0.00004267885,0.000001128131,0.00006787533,5.970869e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000009249377,"about_ca_system_score_gemma":0.00003962816,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007623666,"about_ca_topic_score_gemma":0.0001581148,"domain_scores_codex":[0.9992683,0.00006290092,0.000257208,0.0001614483,0.00013034,0.0001197826],"domain_scores_gemma":[0.9996018,0.0001187243,0.00006754775,0.0001067527,0.00007804786,0.00002715017],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001326031,0.0003375976,0.05167801,0.002322006,0.0000905483,0.00009911076,0.1202558,0.00004902694,0.8110197,0.0003085874,0.00001520663,0.01249839],"study_design_scores_gemma":[0.007741278,0.0001666637,0.09130151,0.001388901,0.0002070595,0.00002975354,0.0082081,0.0001063057,0.8902337,0.0001328298,0.0003286405,0.000155288],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.985175,0.00409343,0.009660696,0.0002173705,0.00004194011,0.0003968424,0.00008046919,0.000009798253,0.0003244458],"genre_scores_gemma":[0.9768026,0.02179295,0.0005558578,0.0002464709,0.0000293479,0.00003659604,0.0004041886,0.00001398402,0.0001179392],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1120477,"threshold_uncertainty_score":0.3479414,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388036682","doi":"10.1016/j.jtct.2023.10.018","title":"Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation","year":2023,"lang":"en","type":"review","venue":"Transplantation and Cellular Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; Office of Naval Research; National Heart, Lung, and Blood Institute; Genentech; Health Resources and Services Administration; Swedish Orphan Biovitrum; National Institute of Environmental Health Sciences; Servier; Gateway for Cancer Research; Astellas Pharma; Sanofi; MacroGenics; Incyte; Leukemia and Lymphoma Society","keywords":"Hematopoietic stem cell transplantation; Medicine; Transplantation; Genetic testing; Germline; Oncology; CEBPA; Immunology; Internal medicine; Genetics; Biology; Mutation; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.09424667534191573,"gpt":0.3399268667014665,"spread":0.2456801913595508,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003741112,0.0005594503,0.001419095,0.0005776287,0.00008943513,0.00004129804,0.0001114267,0.0004796736,0.00002466788],"category_scores_gemma":[0.000001372677,0.0004869404,0.0001775786,0.0004050432,0.0001744451,0.00009309014,0.00000944697,0.0004494723,0.000008906328],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006781118,"about_ca_system_score_gemma":0.0002188527,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002261321,"about_ca_topic_score_gemma":0.00007756805,"domain_scores_codex":[0.9970295,0.0003976801,0.001073959,0.0006945326,0.0004166529,0.0003877087],"domain_scores_gemma":[0.9988838,0.00024799,0.0003293491,0.0002621032,0.00006808395,0.0002086255],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001386472,0.000265639,0.001237941,0.1595044,0.0004450964,0.001329401,0.01494691,0.00001585445,0.01215348,0.00007022962,0.000007763198,0.8086368],"study_design_scores_gemma":[0.1337966,0.0143213,0.04747292,0.1944061,0.0385301,0.01621547,0.01044317,0.001804186,0.4547561,0.001220361,0.07367151,0.0133622],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.4148305,0.5827012,0.0004553959,0.00002349176,0.00005212958,0.001618239,0.0002383938,0.00003727241,0.00004330382],"genre_scores_gemma":[0.05442598,0.9436996,0.0002378527,0.00003861861,0.00003288438,0.0001773307,0.001205478,0.0001076911,0.00007458247],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7952746,"threshold_uncertainty_score":0.9997582,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3194157976","doi":"10.1016/j.jtct.2021.08.007","title":"Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; National Heart, Lung, and Blood Institute; U.S. Public Health Service; Health Resources and Services Administration; CytoSen Therapeutics; Kiadis Pharma; Pfizer; Incyte; Kyowa Kirin Pharmaceutical Development; Jazz Pharmaceuticals; Medical College of Wisconsin; Takeda Pharmaceuticals U.S.A.; Meso Scale Diagnostics; AbbVie; National Cancer Institute; Gilead Sciences; Karyopharm Therapeutics; Celgene; Novartis; GlaxoSmithKline; Otsuka America; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Roche; Astellas Pharma US; Falk Foundation; CareDx; Daiichi-Sankyo","keywords":"Medicine; Fludarabine; Busulfan; Melphalan; Alemtuzumab; Internal medicine; Transplantation; Regimen; Hematopoietic stem cell transplantation; Cumulative incidence; Incidence (geometry); Surgery; Gastroenterology; Oncology; Chemotherapy; Cyclophosphamide","retraction":null,"screen_n_in":null,"score":{"opus":0.01111338953044004,"gpt":0.245643071941076,"spread":0.234529682410636,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001234766,0.0002420425,0.0005047974,0.0001864408,0.00006292712,0.00002747991,0.00003975033,0.00008338458,0.00003549747],"category_scores_gemma":[0.000005326668,0.0001696988,0.0000249954,0.000238073,0.0001822443,0.0001449708,0.000004321655,0.0001777406,5.1889e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002528081,"about_ca_system_score_gemma":0.0001076905,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000797422,"about_ca_topic_score_gemma":0.00009254855,"domain_scores_codex":[0.9986408,0.00009648408,0.000319714,0.0003803438,0.0003357922,0.0002268389],"domain_scores_gemma":[0.9993521,0.0001315674,0.00008270712,0.0001490612,0.0001496788,0.0001348839],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01036458,0.0005947738,0.630441,0.001696384,0.0003961203,0.0005709264,0.00701294,0.00001839225,0.3432226,0.00009196906,0.000003371647,0.005586884],"study_design_scores_gemma":[0.02601505,0.0009524517,0.8310705,0.0003430012,0.0001849292,0.000203059,0.0003892428,0.0001789015,0.1404332,0.00001601996,0.000007843891,0.0002058029],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974103,0.0006743775,0.000656653,0.0003707172,0.00002152413,0.000678829,0.00009272002,0.00002395888,0.00007094211],"genre_scores_gemma":[0.9944043,0.00393739,0.0007651353,0.00009192858,0.000009132086,0.00002854323,0.0006221629,0.00003160297,0.0001097833],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2027894,"threshold_uncertainty_score":0.6920117,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4285679625","doi":"10.1016/j.jtct.2022.07.013","title":"Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"Defense Systems Management College; National Institute of Allergy and Infectious Diseases; Daiichi Sankyo Europe; National Cancer Institute; Office of Naval Research; National Heart, Lung, and Blood Institute; Pharmacyclics; Chugai Pharmaceutical; Merck Sharp and Dohme; U.S. Public Health Service; National Institutes of Health; Daiichi-Sankyo; Omeros Corporation; Astellas Pharma; Astellas Pharma US; Nippon Shinyaku; Incyte; Pfizer; CareDx; Plexxikon; Health Resources and Services Administration; Syndax Pharmaceuticals; Kyowa Kirin Pharmaceutical Development; Legend Biotech; CytoSen Therapeutics; Cancer Moonshot; Medical College of Wisconsin; Cidara Therapeutics; Novartis; Celgene; Moonshot Research and Development Program; Sanofi; Janssen Pharmaceuticals; Fuji Pharma; Merck; Bristol-Myers Squibb","keywords":"Medicine; Graft-versus-host disease; Internal medicine; Transplantation; Gastroenterology; Cyclophosphamide; Hazard ratio; Retrospective cohort study; Immunology; Surgery; Chemotherapy; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.01432678059424721,"gpt":0.2437695142646835,"spread":0.2294427336704362,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002515759,0.000281754,0.0003561178,0.000194449,0.0001991782,0.00002243334,0.00009902797,0.00008502694,0.00310055],"category_scores_gemma":[0.000007220333,0.000286119,0.0001828691,0.0002432442,0.0001318456,0.0001352162,0.000006870749,0.0002513079,0.00001687119],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005912843,"about_ca_system_score_gemma":0.0001624544,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003916076,"about_ca_topic_score_gemma":0.000006186838,"domain_scores_codex":[0.9978565,0.000170751,0.0005810096,0.0004114646,0.0007116429,0.0002686144],"domain_scores_gemma":[0.9990267,0.0001824083,0.0001859285,0.0002299309,0.0001487246,0.0002263293],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4687872,0.003302002,0.2102637,0.01075261,0.00158829,0.00514795,0.02455236,0.00009605297,0.2275773,0.005388387,0.00003735154,0.04250687],"study_design_scores_gemma":[0.02660466,0.002388916,0.9271567,0.00008898013,0.0008319323,0.0001102026,0.0005868706,0.00008682427,0.04072117,0.00005654073,0.0008506743,0.0005165178],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926603,0.00104699,0.002455706,0.0002281952,0.0008577144,0.0009133801,0.001142434,0.00007428665,0.000621027],"genre_scores_gemma":[0.9907331,0.004592728,0.0003054204,0.0001926954,0.00005774052,0.0002111792,0.003691138,0.00004912521,0.0001668231],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.716893,"threshold_uncertainty_score":0.9999591,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4312156831","doi":"10.1016/j.jtct.2022.12.013","title":"An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Hematopoietic stem cell transplantation; Medicine; Myeloid leukemia; Transplantation; Incidence (geometry); Disease; Disease burden; Internal medicine; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.02364477451200672,"gpt":0.2934058069284788,"spread":0.2697610324164721,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003710087,0.0001354086,0.0003545315,0.0003172071,0.0001765787,0.000009009731,0.0001586812,0.00005484968,0.0001278327],"category_scores_gemma":[7.024603e-7,0.000106971,0.0002063745,0.0008556831,0.00008048631,0.00007577255,0.000005216881,0.0001409766,2.77045e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009061077,"about_ca_system_score_gemma":0.0001705803,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000616548,"about_ca_topic_score_gemma":0.0000187655,"domain_scores_codex":[0.9985786,0.000194685,0.0003962064,0.0002438489,0.0004257271,0.0001609509],"domain_scores_gemma":[0.9992727,0.0001014774,0.0001807401,0.0002777946,0.000102221,0.00006506531],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00461971,0.0002492087,0.01049275,0.0006850483,0.001072203,0.0000149896,0.01600303,0.004073739,0.9526646,0.0008281418,0.00001656056,0.009279987],"study_design_scores_gemma":[0.00542126,0.0006749868,0.03528252,0.00002949084,0.003694696,0.00003392225,0.001929813,0.02262419,0.929862,0.0000735255,0.0002119581,0.0001616318],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9664546,0.0004590967,0.03160226,0.0001339131,0.00004261597,0.0008296294,0.0003359953,0.00002093998,0.0001208939],"genre_scores_gemma":[0.9953084,0.0028836,0.0002624738,0.0001540859,0.0000114913,0.0000892592,0.0009728529,0.00002416617,0.0002936888],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03133979,"threshold_uncertainty_score":0.4362151,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4205522471","doi":"10.1016/j.jtct.2022.01.013","title":"Association Between the Magnitude of Intravenous Busulfan Exposure and Development of Hepatic Veno-Occlusive Disease in Children and Young Adults Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; University of Manitoba; CancerCare Manitoba","funders":"Swedish Orphan Biovitrum; Omeros Corporation; Jazz Pharmaceuticals; Sanofi","keywords":"Busulfan; Conditioning regimen; Young adult; Hepatic veno-occlusive disease; Regimen; Hematopoietic stem cell transplantation; Transplantation; Dosing; Hematopoietic cell","retraction":null,"screen_n_in":null,"score":{"opus":0.007827591743464946,"gpt":0.2152293106511451,"spread":0.2074017189076802,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004594084,0.0001898764,0.0003380271,0.0001590164,0.0001842183,0.00001142183,0.00007655864,0.00006594892,0.00002717925],"category_scores_gemma":[0.000006487653,0.0001681964,0.00003822628,0.0001781286,0.00006559166,0.00006917507,0.00001027427,0.0001729668,3.89642e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005736407,"about_ca_system_score_gemma":0.0001265944,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001139508,"about_ca_topic_score_gemma":0.00006749033,"domain_scores_codex":[0.9983217,0.0002490986,0.0005567155,0.0002773678,0.0004140192,0.0001810706],"domain_scores_gemma":[0.9992246,0.0002355279,0.0002651176,0.0001299829,0.00005760803,0.00008714847],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001135109,0.0001737068,0.9000223,0.001483685,0.000200915,0.00002534814,0.0716396,0.00008360842,0.0214767,0.00003105515,4.117935e-7,0.003727597],"study_design_scores_gemma":[0.00534401,0.0003143127,0.9353853,0.0002451196,0.0003648464,0.0000537207,0.001614301,0.00006113637,0.05633986,0.0001087625,0.000002024059,0.0001666137],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947849,0.00185681,0.001991879,0.0001304852,0.00002718541,0.00102507,0.0001343008,0.0000146965,0.00003465664],"genre_scores_gemma":[0.9928049,0.00580905,0.0006198272,0.00003886466,0.00001277975,0.0000561423,0.0006203917,0.00002300904,0.00001501685],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0700253,"threshold_uncertainty_score":0.685885,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4293652654","doi":"10.1016/j.jtct.2022.08.021","title":"Ibrutinib Treatment of Pediatric Chronic Graft-versus-Host Disease: Primary Results from the Phase 1/2 iMAGINE Study","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"Janssen Pharmaceuticals; Incyte; Fondazione IRCCS Policlinico San Matteo; Pharmacyclics; AbbVie; Jazz Pharmaceuticals; Novartis; Teva Pharmaceutical Industries; Gilead Sciences; GlaxoSmithKline; Amgen","keywords":"Ibrutinib; Medicine; Internal medicine; Clinical endpoint; Hematopoietic stem cell transplantation; Adverse effect; Refractory (planetary science); Graft-versus-host disease; Transplantation; Gastroenterology; Clinical trial; Leukemia; Chronic lymphocytic leukemia","retraction":null,"screen_n_in":null,"score":{"opus":0.04040375757232324,"gpt":0.3183749669695803,"spread":0.2779712093972571,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002280661,0.0001658204,0.0002430519,0.00007088503,0.0002012136,0.00001498777,0.0001153324,0.0000207096,0.0003142735],"category_scores_gemma":[0.000004858095,0.0001131406,0.00009117066,0.0002442808,0.00007666948,0.00004247158,0.00001298599,0.0001111983,0.000005061254],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001327677,"about_ca_system_score_gemma":0.001555259,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006114367,"about_ca_topic_score_gemma":0.00002204251,"domain_scores_codex":[0.9983782,0.0002120996,0.0003270461,0.0003296162,0.0005509366,0.0002021157],"domain_scores_gemma":[0.9990317,0.0003321954,0.00009054095,0.0003842589,0.00003552277,0.0001258021],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5398884,0.03499109,0.02405245,0.00079413,0.003839493,0.006271279,0.08973291,0.0004648053,0.1672973,0.0001965313,0.001417957,0.1310537],"study_design_scores_gemma":[0.8875496,0.02072204,0.04579928,0.0000358576,0.002234381,0.000054536,0.002829113,0.003969059,0.0208726,0.00003841218,0.01535715,0.0005379727],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9835335,0.01352389,0.00006419441,0.000506271,0.0001221151,0.001325715,0.0007210117,0.00003510455,0.0001682143],"genre_scores_gemma":[0.9820392,0.01554651,0.00001756666,0.00007661624,0.0002492371,0.0001179559,0.001655791,0.00002351475,0.000273606],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3476612,"threshold_uncertainty_score":0.461374,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3091044444","doi":"10.1016/j.bbmt.2020.09.026","title":"Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research Study","year":2020,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital","funders":"National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; Health Resources and Services Administration","keywords":"Medicine; Myelodysplastic syndromes; Hazard ratio; Internal medicine; Transplantation; Cohort; International Prognostic Scoring System; Oncology; Lower risk; Hematopoietic stem cell transplantation; Leukemia; Confidence interval; Surgery; Bone marrow","retraction":null,"screen_n_in":null,"score":{"opus":0.02891031571224549,"gpt":0.2975582630253778,"spread":0.2686479473131323,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007720965,0.0003763032,0.000527689,0.000340702,0.0003492054,0.000112805,0.0001921985,0.000120595,0.00001048299],"category_scores_gemma":[0.0001410488,0.0003202105,0.00009278449,0.0001914124,0.0002925096,0.0002401914,0.00001486159,0.000348927,6.273494e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001021496,"about_ca_system_score_gemma":0.00034584,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001129918,"about_ca_topic_score_gemma":0.0002147965,"domain_scores_codex":[0.9971428,0.0002617036,0.000566853,0.0009096968,0.0005749378,0.0005439988],"domain_scores_gemma":[0.9976265,0.001095291,0.0001205576,0.0002039185,0.0004192002,0.0005345365],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6235729,0.001624129,0.2370899,0.004683168,0.00422993,0.002784986,0.05043399,0.0005422109,0.06920889,0.0003633303,0.0000483484,0.005418183],"study_design_scores_gemma":[0.1830288,0.009274886,0.7663388,0.0008478467,0.002641178,0.000143866,0.002695917,0.01745391,0.01603547,0.0005039136,0.0001045373,0.0009309105],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9588046,0.0002484165,0.01855818,0.001291509,0.0001014216,0.005507526,0.0154354,0.0000479025,0.000005054559],"genre_scores_gemma":[0.9860032,0.006566878,0.0005386952,0.0002051112,0.0001874359,0.001264097,0.005104769,0.00008006149,0.0000497429],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5292488,"threshold_uncertainty_score":0.999925,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3195493284","doi":"10.1016/j.jtct.2021.08.010","title":"Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; Ottawa Hospital","funders":"Janssen Pharmaceuticals; Janssen Biotech; Janssen Research and Development; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Patient-Centered Outcomes Research Institute; Sanofi Genzyme; Celgene; U.S. Navy; Health Resources and Services Administration; CytoSen Therapeutics; Kyowa Hakko Kirin; Daiichi-Sankyo; Janssen Scientific Affairs; CSL Behring; BC Children's Hospital; National Institutes of Health; Seattle Genetics; National Heart, Lung, and Blood Institute; Shire; Bristol-Myers Squibb; University of Wisconsin-Madison; Mayo Clinic; Government of South Australia; Pfizer; GlaxoSmithKline; U.S. Department of Defense; Boston Children's Hospital; National Cancer Institute; Gilead Sciences","keywords":"Medicine; Internal medicine; Myeloid leukemia; Regimen; Transplantation; Myelodysplastic syndromes; Leukemia; Hematopoietic stem cell transplantation; Oncology; Surgery; Bone marrow","retraction":null,"screen_n_in":null,"score":{"opus":0.01179765960474035,"gpt":0.2508465873082747,"spread":0.2390489277035343,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002137706,0.0003124199,0.0004419998,0.0003131319,0.0001211605,0.00004318824,0.00008185876,0.0002320476,0.0001794937],"category_scores_gemma":[0.000005156395,0.0002791112,0.00007363419,0.0005214249,0.0000875054,0.0001220182,0.000006754819,0.000314559,0.00003135279],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001879388,"about_ca_system_score_gemma":0.0003169866,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001697495,"about_ca_topic_score_gemma":0.00009330587,"domain_scores_codex":[0.9980536,0.000179235,0.0004232448,0.0005948412,0.0003250554,0.0004240128],"domain_scores_gemma":[0.9992275,0.0001217973,0.00004899157,0.0002245325,0.00009016746,0.0002870111],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.009833612,0.0002010024,0.008683694,0.0006276989,0.000353564,0.0136612,0.01691722,0.0001261629,0.8924906,0.0001794304,0.00001696829,0.05690891],"study_design_scores_gemma":[0.05778856,0.003271096,0.3510418,0.001101543,0.0004814321,0.01798785,0.001048879,0.001472462,0.5637771,0.0003026908,0.0005585254,0.001168055],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930429,0.003879916,0.0009580457,0.0006437663,0.00006224418,0.0008697567,0.00006433974,0.00007366884,0.0004053828],"genre_scores_gemma":[0.9154245,0.08209535,0.0004295382,0.0006584728,0.00002366602,0.00006862797,0.0006774561,0.00005143383,0.000570988],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3423581,"threshold_uncertainty_score":0.9999661,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3089905216","doi":"10.1016/j.bbmt.2020.09.031","title":"UM171-Expanded Cord Blood Transplants Support Robust T Cell Reconstitution with Low Rates of Severe Infections","year":2020,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Centre Hospitalier de l’Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Cord blood; Hematopoietic stem cell transplantation; Transplantation; Immunology; T cell; Medicine; Progenitor cell; Immune system; Stem cell; Incidence (geometry); Graft-versus-host disease; Internal medicine; Haematopoiesis; Gastroenterology; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.02782394291303139,"gpt":0.2478349455561861,"spread":0.2200110026431547,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001147305,0.0002415192,0.000382907,0.0001002248,0.00009879016,0.00001851236,0.00005515264,0.0001332305,0.0003726424],"category_scores_gemma":[0.00000180297,0.0002022168,0.00008408794,0.0002557015,0.0001277992,0.0001447541,0.000001248415,0.0001745033,0.00001644846],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000008586078,"about_ca_system_score_gemma":0.0001333689,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003048355,"about_ca_topic_score_gemma":0.00001593811,"domain_scores_codex":[0.9987043,0.00007041932,0.0004155144,0.0003326775,0.0002710413,0.0002061183],"domain_scores_gemma":[0.9993659,0.0000716276,0.0001239631,0.0001339278,0.00009484728,0.0002096966],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.007917112,0.0009347601,0.07074102,0.004270484,0.0003977971,0.0004362992,0.01046513,0.000484779,0.9016404,0.0002783138,0.00003250834,0.002401378],"study_design_scores_gemma":[0.01501357,0.002808555,0.009762398,0.0003929157,0.0007214946,0.001057971,0.000423245,0.0002584045,0.9690186,0.00001679544,0.0001783728,0.000347642],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9652593,0.0002268479,0.03013208,0.0002904455,0.00005574831,0.0007292494,0.000117737,0.00009611699,0.003092475],"genre_scores_gemma":[0.9922343,0.00541807,0.001165526,0.000349148,0.00004082619,0.00002556553,0.0006330813,0.00003058604,0.0001028607],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06737822,"threshold_uncertainty_score":0.8246163,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4382932713","doi":"10.1016/j.jtct.2023.06.020","title":"Impact of Donor Age on Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Adults with Acute Myeloid Leukemia","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; MorphoSys; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; TG Therapeutics; Jazz Pharmaceuticals; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; StemCyte; Bristol-Myers Squibb; AstraZeneca; CSL Behring; BeiGene; HistoGenetics; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Sanofi; GlaxoSmithKline; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Amgen; Mallinckrodt Pharmaceuticals; Astellas Pharma US","keywords":"Medicine; Hazard ratio; Cumulative incidence; Transplantation; Myeloid leukemia; Internal medicine; Cohort; Hematopoietic stem cell transplantation; Hematopoietic cell; Surgery; Incidence (geometry); Retrospective cohort study; Confidence interval; Graft-versus-host disease; Haematopoiesis; Stem cell","retraction":null,"screen_n_in":null,"score":{"opus":0.01402042911838735,"gpt":0.2828669312739773,"spread":0.26884650215559,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002096763,0.0002670847,0.0004412311,0.0004333261,0.0000505578,0.00001649073,0.00009636339,0.0001374926,0.00009074547],"category_scores_gemma":[0.000001464522,0.0001854942,0.0001334654,0.0004872862,0.00008636956,0.00008683177,0.000002969688,0.0002489444,0.00002811764],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001260298,"about_ca_system_score_gemma":0.0001944233,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002709983,"about_ca_topic_score_gemma":0.00005610122,"domain_scores_codex":[0.9984685,0.00009522738,0.0003469711,0.000354022,0.000390827,0.0003444713],"domain_scores_gemma":[0.9993901,0.0001194742,0.00008023752,0.0002243967,0.00004918289,0.0001366459],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.03268531,0.0008015557,0.3317977,0.002190511,0.0008053781,0.006843458,0.03608216,0.000731831,0.5776442,0.0001010977,0.00007954743,0.01023728],"study_design_scores_gemma":[0.02043474,0.001605187,0.8094896,0.0003419193,0.0001350929,0.0001464142,0.0003629308,0.000241472,0.1669528,0.00002482813,0.000008711288,0.000256326],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977409,0.0001461142,0.0004581659,0.0001409476,0.00002347809,0.0009505902,0.00007988014,0.00007620972,0.0003836836],"genre_scores_gemma":[0.9864187,0.01197055,0.0001571905,0.0001142466,0.00001607049,0.00006544308,0.000775472,0.00004806115,0.00043433],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4776919,"threshold_uncertainty_score":0.7564232,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3157866779","doi":"10.1016/j.jtct.2021.04.013","title":"Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Hospital for Sick Children; University of Calgary","funders":"National Center for Advancing Translational Sciences; Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; Sanofi Genzyme; Merck Sharp and Dohme; U.S. Public Health Service; Genentech; Health Resources and Services Administration; National Institutes of Health; Astellas Pharma; Kite Pharma; Meiji Seika Pharma; Daiichi-Sankyo; Vertex Pharmaceuticals; Omeros Corporation; Pfizer; Incyte; Kiadis Pharma; bluebird bio; Kyowa Kirin Pharmaceutical Development; National Institute of Allergy and Infectious Diseases; Angiocrine Bioscience; Cancer Moonshot; Medical College of Wisconsin; StemCyte; Bristol-Myers Squibb; CSL Behring; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Celgene; Actinium Pharmaceuticals; Daiichi Sankyo Europe; National Cancer Institute; Servier; Gilead Sciences; AbbVie; Moonshot Research and Development Program; Sanofi; Amgen; Jazz Pharmaceuticals; Intel Corporation; Astellas Pharma US","keywords":"Medicine; Psychosocial; Transplantation; Hematopoietic cell; Confidence interval; Young adult; Odds ratio; Population; Comorbidity; Logistic regression; Gerontology; Internal medicine; Psychiatry; Haematopoiesis; Stem cell","retraction":null,"screen_n_in":null,"score":{"opus":0.0172365986715323,"gpt":0.2599055968319248,"spread":0.2426689981603925,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004935923,0.0001824866,0.0003002438,0.0001597055,0.00006302017,0.00002543784,0.00009752514,0.00009314514,0.00007433215],"category_scores_gemma":[0.000008421893,0.0001475064,0.00008421282,0.0006979379,0.00006826063,0.00005734737,0.000002577393,0.0001760742,0.000004024956],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001580562,"about_ca_system_score_gemma":0.0000551857,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001889248,"about_ca_topic_score_gemma":0.002247327,"domain_scores_codex":[0.9982508,0.0003955408,0.0004683688,0.0002808499,0.0004006395,0.000203829],"domain_scores_gemma":[0.9992318,0.0002035518,0.00009359933,0.0002382911,0.0001189228,0.0001138437],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00287166,0.0006548474,0.6196849,0.002246662,0.0001404514,0.0005559119,0.3209797,0.0003953959,0.05111379,0.0004054001,0.00008922655,0.0008620959],"study_design_scores_gemma":[0.008074515,0.0004387258,0.6122298,0.0008836666,0.0002619754,0.0001910225,0.02221259,0.00008222766,0.3544336,0.0003662622,0.0003327911,0.0004928201],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923634,0.0009923624,0.003782465,0.001975421,0.00008368747,0.0005001311,0.00003651368,0.0000295424,0.000236512],"genre_scores_gemma":[0.98551,0.0104616,0.0002720395,0.002609281,0.00003125901,0.00002846703,0.0009795651,0.00002390608,0.00008391603],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3033198,"threshold_uncertainty_score":0.6015136,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4220887944","doi":"10.1016/j.jtct.2022.03.016","title":"UM171 Expansion of Cord Blood Improves Donor Availability and HLA Matching For All Patients, Including Minorities","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Cord blood; Transplantation; Stem cell; Human leukocyte antigen; Medicine; Bone marrow; Immunology; Internal medicine; Oncology; Biology; Antigen; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.02708554488530717,"gpt":0.267616644892491,"spread":0.2405311000071839,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003065965,0.0001424021,0.0002578002,0.00008832094,0.0001785381,0.0000128105,0.00004272854,0.00004833926,0.00006072998],"category_scores_gemma":[0.000003040891,0.000135077,0.00005963764,0.00006372379,0.00005752563,0.00007721173,0.000007077278,0.00009709685,2.863253e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001477249,"about_ca_system_score_gemma":0.00002953262,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008038921,"about_ca_topic_score_gemma":0.000005379953,"domain_scores_codex":[0.9989377,0.00007881733,0.0003507331,0.000253958,0.0002292994,0.0001494923],"domain_scores_gemma":[0.9994966,0.0001636985,0.0001044893,0.0001128127,0.00005611177,0.00006622969],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003449273,0.00032462,0.02106521,0.002369482,0.000133779,0.00001001077,0.01692726,0.000004602609,0.9429518,0.0004567695,0.000008515186,0.01229867],"study_design_scores_gemma":[0.02476808,0.003981895,0.06145572,0.0002518687,0.0008293973,0.0001460612,0.005126839,0.0003773938,0.9002333,0.00130499,0.001004712,0.0005197183],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945825,0.000881312,0.003157262,0.00009047553,0.00009454057,0.0009098583,0.0001359321,0.00003230856,0.0001158615],"genre_scores_gemma":[0.9955356,0.001916558,0.001666256,0.0001768976,0.00002011913,0.00009486076,0.0004848395,0.00002161798,0.00008332672],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04271848,"threshold_uncertainty_score":0.5508282,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3135541068","doi":"10.1016/j.jtct.2021.02.030","title":"Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell Transplantation","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital","funders":"Janssen Biotech; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Biomedical Advanced Research and Development Authority; U.S. Navy; National Institutes of Health; Kyowa Kirin Pharmaceutical Development; Bayer Fund; Jazz Pharmaceuticals; National Heart, Lung, and Blood Institute; Shire; CSL Behring; AbbVie; Sanofi Genzyme; Kite Pharma; Stanford University; Pfizer; Daiichi-Sankyo; Falk Foundation; U.S. Department of Defense; U.S. Public Health Service; Alexion Pharmaceuticals; Health Resources and Services Administration; Astellas Pharma US; Boston Children's Hospital; National Cancer Institute; Gilead Sciences","keywords":"Medicine; Transplantation; Hazard ratio; Internal medicine; Cohort; Dialysis; Renal function; Hematopoietic stem cell transplantation; Kidney transplantation; Population; Incidence (geometry); Oncology; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.01546700294401437,"gpt":0.2661724896296553,"spread":0.2507054866856409,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002096599,0.0003950548,0.0005496292,0.0002527997,0.00008888287,0.0000314491,0.0000607123,0.0002403392,0.0006742914],"category_scores_gemma":[0.000003728547,0.0003323187,0.0003644381,0.0003145641,0.00008473496,0.0001665089,0.000001921036,0.0002206796,0.00003793905],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000511981,"about_ca_system_score_gemma":0.0001635481,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003688984,"about_ca_topic_score_gemma":0.00001499785,"domain_scores_codex":[0.9977359,0.0001897023,0.0006717733,0.0005239305,0.0005657596,0.0003129504],"domain_scores_gemma":[0.99897,0.0001750938,0.0001696294,0.0003085465,0.000186255,0.0001905284],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00819166,0.0009283218,0.2562677,0.00229102,0.0004173799,0.0008642803,0.005992285,0.0002716095,0.7215759,0.0002145896,0.00001453989,0.002970759],"study_design_scores_gemma":[0.007157073,0.0007007461,0.4593643,0.0003277815,0.0004558623,0.0005033436,0.00009298963,0.00005352617,0.5309637,0.00008546274,0.00002002714,0.0002752556],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9773198,0.0007628805,0.01909379,0.0001065777,0.0001317923,0.0006268459,0.0001768005,0.00008259364,0.00169888],"genre_scores_gemma":[0.9873872,0.009798586,0.0008070389,0.0002163682,0.00003906164,0.00006674331,0.001310222,0.0000568638,0.0003178707],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2030966,"threshold_uncertainty_score":0.9999129,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3161641015","doi":"10.1016/j.jtct.2021.04.030","title":"Donor-Specific Antibodies and Primary Graft Failure in Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis","year":2021,"lang":"en","type":"review","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Major Science and Technology Projects of China; National Key Research and Development Program of China; Priority Academic Program Development of Jiangsu Higher Education Institutions; National Natural Science Foundation of China","keywords":"Medicine; Cochrane Library; Meta-analysis; Internal medicine; Odds ratio; Hematopoietic stem cell transplantation; Confidence interval; Subgroup analysis; Human leukocyte antigen; Transplantation; Oncology; Surgery; Immunology; Antigen","retraction":null,"screen_n_in":null,"score":{"opus":0.05627700125596914,"gpt":0.2953017753576976,"spread":0.2390247741017285,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000860585,0.0009982561,0.008444875,0.0006890664,0.0001303044,0.0001240521,0.0001465013,0.0004619686,0.0001790186],"category_scores_gemma":[0.000001528377,0.0007428075,0.001269764,0.0009934091,0.000146761,0.0001525687,0.000009739936,0.0004663452,0.000009668298],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004770539,"about_ca_system_score_gemma":0.0001290663,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001411797,"about_ca_topic_score_gemma":0.00003717191,"domain_scores_codex":[0.9949524,0.001001296,0.001960752,0.001133295,0.0005447802,0.0004074747],"domain_scores_gemma":[0.9980437,0.0004796051,0.0005442132,0.0005714977,0.000103208,0.0002577495],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00003580222,0.000112252,0.00003470456,0.974077,0.0211796,0.0007598353,0.00216108,5.359637e-7,0.00007190927,0.000101414,0.00000706638,0.001458819],"study_design_scores_gemma":[0.002165634,0.0001267187,0.00005341968,0.07488913,0.9132166,0.003457913,0.0003398768,0.00000243468,0.0003124367,0.00001130077,0.00434999,0.001074553],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005000104,0.9930989,0.001233014,0.0001867361,0.00002769199,0.004488768,0.0002699685,0.00006334043,0.0001315926],"genre_scores_gemma":[0.0008101214,0.9949193,0.0004796337,0.0004207332,0.00001653011,0.0005929632,0.002314398,0.00009798736,0.0003483181],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8991879,"threshold_uncertainty_score":0.9995023,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4385077092","doi":"10.1016/j.jtct.2023.07.015","title":"Younger Matched Unrelated Donors Confer Decreased Relapse Risk Compared to Older Sibling Donors in Older Patients with B Cell Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; MorphoSys; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; TG Therapeutics; Medac; Jazz Pharmaceuticals; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; StemCyte; Bristol-Myers Squibb; AstraZeneca; CSL Behring; BeiGene; HistoGenetics; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Sanofi; GlaxoSmithKline; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Amgen; Mallinckrodt Pharmaceuticals; Astellas Pharma US","keywords":"Medicine; Hazard ratio; Cumulative incidence; Transplantation; Internal medicine; Cohort; Sibling; Retrospective cohort study; Hematopoietic stem cell transplantation; Confidence interval; Hematopoietic cell; Graft-versus-host disease; Leukemia; Surgery; Incidence (geometry); Cohort study; Haematopoiesis; Stem cell","retraction":null,"screen_n_in":null,"score":{"opus":0.009848070875793475,"gpt":0.2380813251257432,"spread":0.2282332542499497,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003694021,0.0005145603,0.0006133249,0.0008190328,0.0002110118,0.00008614594,0.0001720912,0.000287587,0.0001755833],"category_scores_gemma":[0.00001081582,0.0004354926,0.0001127689,0.001288248,0.0001069595,0.0002382411,0.00001216236,0.0003719593,0.0001297245],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004578522,"about_ca_system_score_gemma":0.0006573094,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004891275,"about_ca_topic_score_gemma":0.0001786782,"domain_scores_codex":[0.9967843,0.0002568547,0.0006952923,0.0007753074,0.0007493273,0.0007389241],"domain_scores_gemma":[0.998301,0.0004731898,0.0001767584,0.0003400374,0.0001723518,0.0005366319],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03416429,0.001732081,0.5305457,0.003383302,0.001103552,0.003146557,0.05594617,0.02057377,0.3475044,0.00005941937,0.000295758,0.001545048],"study_design_scores_gemma":[0.1350576,0.001419706,0.614027,0.001891882,0.001726486,0.000174679,0.002533544,0.01170374,0.2296612,0.00008151672,0.00005470441,0.001667926],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9800082,0.000160407,0.01718547,0.0001313301,0.0001030627,0.001864904,0.000100292,0.0002143551,0.0002319233],"genre_scores_gemma":[0.9897323,0.006541927,0.0007117246,0.0004515456,0.00002666879,0.0001275661,0.001924311,0.0001297543,0.0003542155],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1178431,"threshold_uncertainty_score":0.9998097,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4210253082","doi":"10.1016/j.jtct.2022.02.002","title":"Multiple Breath Washout Testing to Identify Pulmonary Chronic Graft Versus Host Disease in Children After Hematopoietic Stem Cell Transplantation","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"BC Children's Hospital","keywords":"Medicine; Spirometry; Hematopoietic stem cell transplantation; Interquartile range; Transplantation; Graft-versus-host disease; Pediatrics; Population; Internal medicine; Asthma","retraction":null,"screen_n_in":null,"score":{"opus":0.01703160201453879,"gpt":0.2779186825092738,"spread":0.260887080494735,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001917098,0.0002041134,0.0002208147,0.0002315246,0.0001696449,0.00003629058,0.0001017405,0.00003338165,0.0001641724],"category_scores_gemma":[0.000003728448,0.0002024976,0.0000676097,0.0003713175,0.00004435728,0.0001322146,0.00001218974,0.000235376,0.00001552732],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001207252,"about_ca_system_score_gemma":0.00009859723,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001338391,"about_ca_topic_score_gemma":0.00003311393,"domain_scores_codex":[0.9983149,0.0001395778,0.000295151,0.000421395,0.0004940126,0.0003349319],"domain_scores_gemma":[0.9993156,0.000162411,0.00004711623,0.0001896578,0.00003192681,0.0002533567],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.02313372,0.0005840716,0.4281364,0.001037555,0.00006412228,0.001415853,0.004781331,0.001318172,0.5271636,0.00001116344,0.000005588278,0.01234839],"study_design_scores_gemma":[0.01172345,0.0009927802,0.948877,0.0002351008,0.0001391283,0.0002297847,0.000400697,0.001828218,0.03500574,0.00002377543,0.0001457541,0.0003985593],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927263,0.004379863,0.001107849,0.0001642216,0.00007820694,0.001177729,0.0002325826,0.00006369474,0.00006955289],"genre_scores_gemma":[0.9970899,0.001452173,0.0002300549,0.0001005996,0.00004805932,0.000370431,0.0005557722,0.00004032219,0.0001126513],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5207406,"threshold_uncertainty_score":0.8257612,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4308987982","doi":"10.1016/j.jtct.2022.11.007","title":"Clinical Outcomes of Umbilical Cord Blood Transplantation Using Ex Vivo Expansion: A Systematic Review and Meta-Analysis of Controlled Studies","year":2022,"lang":"en","type":"review","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Blood Services; Ottawa Hospital; University of Ottawa","funders":"Ottawa Hospital Research Institute","keywords":"Medicine; Ex vivo; Umbilical Cord Blood Transplantation; Umbilical cord; Transplantation; Stem cell; CD34; Internal medicine; Cord blood; Oncology; Hematopoietic stem cell transplantation; Immunology; In vivo; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.2462040315036363,"gpt":0.4383533494280599,"spread":0.1921493179244236,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.002179109,0.0006410346,0.01626668,0.0005650521,0.00008614225,0.00001212341,0.0001417815,0.0002714974,0.0004468523],"category_scores_gemma":[0.00005431112,0.0004154089,0.003564751,0.0007472499,0.0002164015,0.00006968608,0.00000766481,0.0003158725,6.603504e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002107017,"about_ca_system_score_gemma":0.000137546,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003130027,"about_ca_topic_score_gemma":0.00001012761,"domain_scores_codex":[0.9927451,0.001817105,0.003855355,0.0006456221,0.0007251778,0.0002116407],"domain_scores_gemma":[0.9947665,0.00276833,0.001644675,0.0005062267,0.0001717339,0.0001425303],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0004389255,0.000287286,0.00004750919,0.7379287,0.2594325,0.00008790382,0.0008289476,0.000001163305,0.00005401628,0.00005600134,7.628357e-7,0.0008363103],"study_design_scores_gemma":[0.004746962,0.0004372388,0.00002187711,0.01969022,0.9739296,0.0003695831,0.0001799072,0.00002286608,0.00008036037,0.000005997463,0.0001931969,0.0003221197],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002838158,0.9898565,0.0007675753,0.00003085558,0.00005198792,0.005810721,0.0005825594,0.0000298265,0.00003184519],"genre_scores_gemma":[0.001127639,0.996986,0.0004373142,0.0002059623,0.000009239073,0.0004050621,0.0006940693,0.00005462425,0.00008009317],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7182385,"threshold_uncertainty_score":0.9998298,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3135819089","doi":"10.1016/j.jtct.2021.02.034","title":"The Future of Chronic Graft-Versus-Host Disease: Introduction to the 2020 National Institutes of Health Consensus Development Project Reports","year":2021,"lang":"en","type":"editorial","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"British Columbia Children's Hospital","funders":"National Cancer Institute; National Institutes of Health; AstraZeneca; Amgen","keywords":"Host (biology); Consensus conference; Medicine; Political science; Biology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01562438957506369,"gpt":0.2888473088413381,"spread":0.2732229192662745,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001091908,0.0002607767,0.0004536101,0.0001000605,0.0002586883,0.00002689108,0.0000942746,0.0001866139,0.00002267943],"category_scores_gemma":[0.00005192931,0.0001685777,0.0001098919,0.0002982234,0.000131791,0.00002936788,0.00000594724,0.0003008555,0.000001562771],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001387935,"about_ca_system_score_gemma":0.003964724,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000412783,"about_ca_topic_score_gemma":0.0001681348,"domain_scores_codex":[0.9970509,0.0002401681,0.0009282579,0.0004149249,0.001164943,0.0002008296],"domain_scores_gemma":[0.9981934,0.0003847255,0.0004937978,0.0002977939,0.0005369402,0.00009331614],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01468343,0.0007634877,0.0002854212,0.01502451,0.00224948,0.0003684312,0.01937442,0.0001469863,0.01778365,0.0009973242,0.8798969,0.04842597],"study_design_scores_gemma":[0.00248382,0.0003235053,0.0006096521,0.0006608303,0.0001830535,0.00005530688,0.0004736482,0.00001260535,0.01371469,0.00001327182,0.9812766,0.0001929591],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.04556262,0.1182021,0.004036477,0.02738259,0.7963388,0.007280866,0.0007781622,0.0001192283,0.0002991856],"genre_scores_gemma":[0.07178634,0.2077453,0.001658324,0.0002882006,0.695358,0.0005366524,0.02122599,0.0001688225,0.00123237],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.1013798,"threshold_uncertainty_score":0.703325,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4207010819","doi":"10.1016/j.jtct.2022.01.017","title":"Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital","funders":"Janssen Pharmaceuticals; National Institute of Allergy and Infectious Diseases; Office of Naval Research; National Heart, Lung, and Blood Institute; U.S. Public Health Service; Health Resources and Services Administration; U.S. Food and Drug Administration; Astellas Pharma; Daiichi-Sankyo; Bayer Fund; Kiadis Pharma; TG Therapeutics; Medical College of Wisconsin; Chimerix; Jazz Pharmaceuticals; Takeda Pharmaceuticals U.S.A.; AbbVie; Merck; Spectrum Pharmaceuticals; National Cancer Institute; Gilead Sciences; Karyopharm Therapeutics; Novartis; GlaxoSmithKline; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Amgen; Falk Foundation; CareDx; Amyloidosis Foundation; Pfizer; Alexion Pharmaceuticals; Astellas Pharma US","keywords":"Medicine; Internal medicine; Hazard ratio; Transplantation; Prolymphocytic leukemia; Regimen; Cumulative incidence; Gastroenterology; Hematopoietic stem cell transplantation; Alemtuzumab; Oncology; Confidence interval; Leukemia; Surgery; Chronic lymphocytic leukemia","retraction":null,"screen_n_in":null,"score":{"opus":0.0394564369277786,"gpt":0.3046050989104168,"spread":0.2651486619826382,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009834758,0.0001942072,0.0004289884,0.0003771468,0.0001820594,0.00002968498,0.0002156027,0.00008936111,0.0001505469],"category_scores_gemma":[0.000008038463,0.0001489228,0.0001670427,0.0004213072,0.0001615795,0.00007517288,0.00001547316,0.0002993914,0.000001136208],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005611634,"about_ca_system_score_gemma":0.0009958134,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001193249,"about_ca_topic_score_gemma":0.0001245304,"domain_scores_codex":[0.9976586,0.000356496,0.0005227872,0.0004383502,0.0007309223,0.0002928587],"domain_scores_gemma":[0.9987274,0.0006964366,0.0001028422,0.0002399094,0.0001392334,0.00009420927],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.02158687,0.001937815,0.610819,0.00200532,0.002643005,0.0008312797,0.06165198,0.0007167724,0.2959194,0.0002247436,0.000109991,0.001553866],"study_design_scores_gemma":[0.2305313,0.002136773,0.1540493,0.0002773167,0.00275497,0.0003116893,0.007414564,0.01457335,0.5847722,0.0006292784,0.001654848,0.0008944661],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928296,0.003362553,0.0008915676,0.0004005854,0.00008163867,0.001349825,0.0007536062,0.00001654079,0.0003141063],"genre_scores_gemma":[0.9911838,0.006245491,0.0001503349,0.0002298844,0.0000339482,0.0003098931,0.001630199,0.00002886447,0.0001876247],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4567697,"threshold_uncertainty_score":0.6072897,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3203453632","doi":"10.1016/j.jtct.2021.09.021","title":"Risk Factors for the Incidence of and the Mortality due to Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell Transplantation","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Calgary Laboratory Services; Alberta Health Services; University of Calgary","funders":"O'Brien Institute for Public Health, University of Calgary; Alberta Cancer Foundation","keywords":"Serostatus; Medicine; Incidence (geometry); Internal medicine; Risk factor; Gastroenterology; Transplantation; Post-transplant lymphoproliferative disorder; Hematopoietic stem cell transplantation; Lymphoproliferative disorders; Cumulative incidence; Immunology; Complication; Lymphoma; Viral load; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.009878284039741236,"gpt":0.2511537374207627,"spread":0.2412754533810215,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002698787,0.0001763428,0.0002966355,0.00003444955,0.0001927518,0.0000294157,0.00005347833,0.00007816577,0.00004549302],"category_scores_gemma":[0.00000963157,0.0001001591,0.0001251773,0.0001351961,0.0001468606,0.00006624937,0.000002508146,0.0001023091,6.923754e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001143212,"about_ca_system_score_gemma":0.00007527176,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000583025,"about_ca_topic_score_gemma":0.0005307082,"domain_scores_codex":[0.9989555,0.000135975,0.0002800099,0.0002433527,0.0002194467,0.0001657078],"domain_scores_gemma":[0.9992067,0.0003480139,0.0000922035,0.0001543263,0.0001264159,0.00007229704],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03791532,0.0006838065,0.5763059,0.002522582,0.001392247,0.0002010145,0.2951223,0.0006236309,0.07109212,0.002038645,0.00002881294,0.0120736],"study_design_scores_gemma":[0.03099311,0.0007602181,0.7191648,0.0002536796,0.002282372,0.0001301777,0.01388926,0.000937283,0.2297203,0.001180928,0.0001867248,0.0005011731],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.971091,0.005704206,0.02063086,0.001118256,0.0000534059,0.0009791292,0.000352213,0.00001484341,0.00005609507],"genre_scores_gemma":[0.9725481,0.02611179,0.00007462678,0.0008718384,0.00001718198,0.0001382663,0.0001684834,0.00001722105,0.00005255321],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2812331,"threshold_uncertainty_score":0.4084368,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3129197373","doi":"10.1016/j.jtct.2021.02.007","title":"Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell Transplantation","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Thymoglobulin; Cumulative incidence; Anti-thymocyte globulin; Transplantation; Gastroenterology; Hematopoietic stem cell transplantation; Cyclophosphamide; Internal medicine; Graft-versus-host disease; Incidence (geometry); Surgery; Tacrolimus; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.02005923419507962,"gpt":0.2617991519393085,"spread":0.2417399177442288,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002228789,0.0004812927,0.0005434436,0.0002037786,0.0002268587,0.0001107227,0.0001076589,0.0002129738,0.00007730067],"category_scores_gemma":[0.00000378954,0.0004505249,0.000169135,0.0004617077,0.0001563795,0.0004125829,0.000003129955,0.0002510692,0.000004515212],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007040756,"about_ca_system_score_gemma":0.0003234641,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001050363,"about_ca_topic_score_gemma":0.0001190715,"domain_scores_codex":[0.9971018,0.000177602,0.0007286267,0.000847433,0.0006117124,0.0005327942],"domain_scores_gemma":[0.9987675,0.0001819777,0.0001454049,0.0002895713,0.0002645568,0.0003510067],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.03045392,0.001047095,0.05666989,0.005670505,0.0001880794,0.005007358,0.0225135,0.0006452644,0.8753297,0.0003645234,4.597741e-7,0.002109659],"study_design_scores_gemma":[0.03553136,0.001340165,0.1411101,0.001014753,0.001263993,0.0008163133,0.002694107,0.001453234,0.8138244,0.00002371125,0.00005854385,0.0008693713],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9471892,0.002215399,0.04818225,0.0001655834,0.0002035482,0.00159839,0.0002502433,0.0001006071,0.00009483236],"genre_scores_gemma":[0.9806643,0.01323192,0.004064151,0.0002166419,0.00006745361,0.0001726708,0.001397559,0.00008867281,0.00009665464],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08444019,"threshold_uncertainty_score":0.9997947,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4313887581","doi":"10.1016/j.jtct.2023.01.004","title":"Multi-Stakeholder Qualitative Interviews to Inform Measurement of Patient Reported Outcomes After CAR-T","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Kite Pharma; Health Resources and Services Administration; MorphoSys; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; TG Therapeutics; Medac; Jazz Pharmaceuticals; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; StemCyte; Bristol-Myers Squibb; AstraZeneca; CSL Behring; BeiGene; HistoGenetics; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Sanofi; GlaxoSmithKline; Novartis Pharmaceuticals Corporation; Amgen; Mallinckrodt Pharmaceuticals; Astellas Pharma US","keywords":"Medicine; Anxiety; Family medicine; Health care; Psychology; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.2083465041368138,"gpt":0.3866332599469373,"spread":0.1782867558101235,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007777422,0.0001640602,0.0003292462,0.0002490842,0.00004120424,0.00001346793,0.00004965929,0.0000599487,0.0006079199],"category_scores_gemma":[0.00001613634,0.0001247642,0.0001191077,0.0003753622,0.00004917619,0.00005433881,0.000007516718,0.0001098875,0.00003426825],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004355061,"about_ca_system_score_gemma":0.0000459501,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009107384,"about_ca_topic_score_gemma":0.00005984885,"domain_scores_codex":[0.9982709,0.0001268426,0.000504482,0.0002262996,0.000659851,0.0002116141],"domain_scores_gemma":[0.9992581,0.00005183891,0.00008551949,0.0002351159,0.0002284074,0.0001410093],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003386856,0.0002537437,0.009556095,0.0003686415,0.0004592435,0.0001507557,0.1956164,0.000008964083,0.7345688,0.00001790097,0.0001065332,0.05550599],"study_design_scores_gemma":[0.01448579,0.001880276,0.1461666,0.0004422684,0.0001744312,0.00003934879,0.02051023,0.0001382598,0.7933505,0.00005081584,0.02221009,0.0005514576],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965134,0.0004237274,0.0009939524,0.000614114,0.00007714876,0.001019796,0.00003364675,0.0000579767,0.0002662681],"genre_scores_gemma":[0.996538,0.001303055,0.0003251905,0.0004908156,0.000009719982,0.0001538651,0.0001125883,0.00002187618,0.001044863],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1751062,"threshold_uncertainty_score":0.6656296,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4387082132","doi":"10.1016/j.jtct.2023.09.017","title":"Incidence and Impact of Fungal Infections in Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis and Haploidentical Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; Gilead Sciences; National Cancer Institute; bluebird bio; Kiadis Pharma; Astellas Pharma; Adaptive Biotechnologies; Incyte; National Heart, Lung, and Blood Institute; Actinium Pharmaceuticals; CareDx; Office of Naval Research; Jazz Pharmaceuticals; Atara Biotherapeutics; Bristol-Myers Squibb; CSL Behring; BeiGene; HistoGenetics; Gateway for Cancer Research; GlaxoSmithKline; Health Resources and Services Administration; Astellas Pharma US; Amgen","keywords":"Medicine; Cumulative incidence; Internal medicine; Transplantation; Incidence (geometry); Proportional hazards model; Graft-versus-host disease; Hematopoietic stem cell transplantation; Cyclophosphamide; Immunology; Calcineurin; Gastroenterology; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.02455374356129006,"gpt":0.3286458289797422,"spread":0.3040920854184522,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006226692,0.0002228177,0.0003640048,0.0006558236,0.0001652401,0.00005748988,0.00006017051,0.0001224766,0.00003727304],"category_scores_gemma":[0.00003352045,0.0001956041,0.0001570037,0.0006555179,0.0002936794,0.0002033339,0.000004404195,0.0002154732,9.416171e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002731307,"about_ca_system_score_gemma":0.000121627,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002586195,"about_ca_topic_score_gemma":0.0006039464,"domain_scores_codex":[0.9981924,0.0001559255,0.000445781,0.0004935269,0.0004190834,0.0002932381],"domain_scores_gemma":[0.9987674,0.0004812416,0.00006991626,0.0001433584,0.0003044584,0.0002336667],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01482201,0.0003984411,0.9183576,0.001731284,0.0003158481,0.0002150613,0.00390861,0.00004544751,0.0596183,0.00009752189,0.000001660677,0.0004881814],"study_design_scores_gemma":[0.009829938,0.001135875,0.9756994,0.0002186338,0.0007983213,0.0000311501,0.0002966097,0.001054891,0.01063316,0.00009939126,0.000003818989,0.0001987888],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944475,0.0009773672,0.002545717,0.0002304046,0.00006199392,0.0008845878,0.0007894658,0.00003619075,0.0000267716],"genre_scores_gemma":[0.9799166,0.01868616,0.0001326156,0.00003170697,0.0000261466,0.00007954295,0.001075775,0.00002090297,0.00003052353],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05734179,"threshold_uncertainty_score":0.7976505,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4385777563","doi":"10.1016/j.jtct.2023.08.009","title":"Choosing Between Older Matched Sibling Donor and Younger Matched Unrelated Donor in Allogeneic Hematopoietic Cell Transplantation: Comparison of Clinical Outcomes in Acute Myeloid Leukemia and Myelodysplastic Syndrome","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Princess Margaret Hospital Foundation","keywords":"Medicine; Incidence (geometry); Transplantation; Myeloid leukemia; Univariate analysis; Internal medicine; Surgery; Graft-versus-host disease; Hematopoietic stem cell transplantation; Retrospective cohort study; Myeloid; Gastroenterology; Multivariate analysis","retraction":null,"screen_n_in":null,"score":{"opus":0.04107198382968032,"gpt":0.3277367237472593,"spread":0.286664739917579,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008163808,0.00039554,0.001322206,0.0006279153,0.00007961407,0.00004040751,0.0000900697,0.0003921767,0.000035412],"category_scores_gemma":[0.000006314684,0.0003651575,0.0001118498,0.0006477978,0.0001666281,0.0002087622,0.000007893363,0.0004321031,0.00001044894],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003780988,"about_ca_system_score_gemma":0.00009525008,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001371787,"about_ca_topic_score_gemma":0.00005796942,"domain_scores_codex":[0.9967896,0.0002472203,0.001570397,0.0006048582,0.0003762729,0.0004116861],"domain_scores_gemma":[0.998486,0.0008022086,0.0002559515,0.000197109,0.00004686694,0.0002118374],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0009908741,0.0001509282,0.9326195,0.002173023,0.00020896,0.0004997405,0.01379279,0.0001213232,0.04826313,0.00002621753,0.000001277105,0.001152305],"study_design_scores_gemma":[0.01408547,0.0002852684,0.9488196,0.0008552058,0.0005463814,0.0002546398,0.001123625,0.0009388443,0.03264168,0.00008448504,0.000004001341,0.0003607568],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951761,0.0008091273,0.0023698,0.000318727,0.000111186,0.00101504,0.00004953064,0.00009331152,0.00005721409],"genre_scores_gemma":[0.9820853,0.01643332,0.0006781975,0.00008641228,0.00001872681,0.00004250481,0.0005221545,0.00005888039,0.0000745162],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01620022,"threshold_uncertainty_score":0.99988,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3215472881","doi":"10.1016/j.jtct.2021.11.009","title":"Outcome of Haploidentical Peripheral Blood Allografts Using Post-Transplantation Cyclophosphamide Compared to Matched Sibling and Unrelated Donor Bone Marrow Allografts in Pediatric Patients with Hematologic Malignancies: A Single-Center Analysis","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Cyclophosphamide; Cumulative incidence; Single Center; Transplantation; Cohort; Internal medicine; Hematopoietic stem cell transplantation; Sibling; Graft-versus-host disease; Incidence (geometry); Bone marrow; Retrospective cohort study; Surgery; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.01966891508687338,"gpt":0.2486617987746787,"spread":0.2289928836878053,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002163316,0.0003257022,0.000808078,0.0005714851,0.00007422939,0.00004931071,0.00005848303,0.0001767591,0.00006759954],"category_scores_gemma":[0.000008525766,0.0002896681,0.0001311889,0.001204681,0.00007469006,0.0001491326,0.000005938964,0.0001643936,0.000001116097],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003410579,"about_ca_system_score_gemma":0.00005427119,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001376751,"about_ca_topic_score_gemma":0.0003688161,"domain_scores_codex":[0.9976441,0.0001613022,0.0008769307,0.0005327127,0.0004413807,0.0003436104],"domain_scores_gemma":[0.9990516,0.0001245014,0.0001742326,0.0001845767,0.0002626927,0.0002023727],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002036278,0.0007476297,0.8423657,0.001051608,0.0003645508,0.0005607546,0.003924672,0.0002946543,0.1485942,0.00001603126,1.569865e-7,0.00004374975],"study_design_scores_gemma":[0.01715843,0.0004680822,0.925504,0.0003982366,0.003156509,0.0003586374,0.0006670445,0.0006322851,0.05121224,0.00001308992,0.000001910127,0.0004295835],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9878417,0.0006028353,0.01042491,0.0001090648,0.00004540584,0.0008184373,0.00008229069,0.00004790111,0.00002748319],"genre_scores_gemma":[0.9916396,0.001313191,0.005720064,0.0002480287,0.00001059433,0.00002422373,0.0009889482,0.00003685228,0.00001846178],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09738196,"threshold_uncertainty_score":0.9999555,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3196532656","doi":"10.1016/j.jtct.2021.08.021","title":"Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; American Society of Pediatric Hematology/Oncology; Pediatric Cancer Foundation; American Society of Hematology","keywords":"Medicine; Elafin; Biomarker; Graft-versus-host disease; Internal medicine; Population; Oncology; Hematopoietic stem cell transplantation; Immunology; Disease; Gastroenterology","retraction":null,"screen_n_in":null,"score":{"opus":0.04697479699653496,"gpt":0.3197217375985809,"spread":0.272746940602046,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005607207,0.000141563,0.0002188429,0.0001338928,0.00003139243,0.0000128203,0.00003275157,0.0000743936,0.0003651334],"category_scores_gemma":[0.0000238339,0.0001338196,0.00006997548,0.0002864714,0.00005134662,0.00007946722,0.000001803321,0.0000794235,0.00001409668],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003079537,"about_ca_system_score_gemma":0.00030643,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002420578,"about_ca_topic_score_gemma":0.00002941776,"domain_scores_codex":[0.9983844,0.0002471269,0.0003284265,0.0002657396,0.0006230215,0.0001513284],"domain_scores_gemma":[0.9993151,0.0001076913,0.00006399605,0.0001605163,0.0002273018,0.0001254027],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.008132242,0.0007887954,0.04644413,0.0009416085,0.0005448259,0.001134729,0.005759498,0.00002763462,0.9122507,0.001062871,0.000007342881,0.02290561],"study_design_scores_gemma":[0.03139943,0.0003592261,0.5730844,0.0007367288,0.002541368,0.0001900423,0.0005382174,0.003740142,0.3863663,0.0005949591,0.0001277672,0.0003213788],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935033,0.002546635,0.001194327,0.0003475046,0.0001044768,0.0007283923,0.00003227255,0.0000243255,0.001518804],"genre_scores_gemma":[0.9939895,0.004989758,0.0002332323,0.0001003875,0.00001027876,0.00006178665,0.000514626,0.00001935065,0.00008107625],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5266403,"threshold_uncertainty_score":0.5457006,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3091239812","doi":"10.1016/j.bbmt.2020.09.035","title":"Acute Respiratory Failure Outcomes in Patients with Hematologic Malignancies and Hematopoietic Cell Transplant: A Secondary Analysis of the EFRAIM Study","year":2020,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sinai Health System; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Transplantation; Odds ratio; Hematopoietic stem cell transplantation; Cohort; Cohort study; Hematopoietic cell; Haematopoiesis; Stem cell","retraction":null,"screen_n_in":null,"score":{"opus":0.01288477810674018,"gpt":0.2274866215903353,"spread":0.2146018434835952,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000133909,0.0002446324,0.0006666366,0.0001835239,0.00006920282,0.00001629147,0.00009102726,0.00009326806,0.00005505048],"category_scores_gemma":[0.000001484184,0.0001524282,0.0001040949,0.0006051597,0.0001091141,0.0000801533,0.000004527843,0.0001826892,0.000001082334],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000008651737,"about_ca_system_score_gemma":0.000042523,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001077969,"about_ca_topic_score_gemma":0.00005426447,"domain_scores_codex":[0.9984925,0.0001479334,0.0004634047,0.0003526617,0.0003661863,0.0001772689],"domain_scores_gemma":[0.9994289,0.00008438719,0.0001341779,0.0001966017,0.00005045565,0.0001054209],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001217146,0.0003989404,0.956252,0.0005348312,0.0007117714,0.00007768788,0.02764899,0.00001308468,0.0130519,0.00003037872,0.000001602793,0.00006168559],"study_design_scores_gemma":[0.01222008,0.0009032944,0.9410151,0.0001012837,0.0023295,0.00001281798,0.00148899,0.00004520796,0.04166631,0.000006826468,0.00001072551,0.0001998763],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974926,0.0002420948,0.0005042011,0.0003821024,0.00001481056,0.001139902,0.0001170006,0.00002850539,0.00007878681],"genre_scores_gemma":[0.998872,0.0001937281,0.00009907726,0.0006936823,0.000003389529,0.00002924779,0.00007554513,0.00002077461,0.00001258363],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02861441,"threshold_uncertainty_score":0.6215842,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4310641319","doi":"10.1016/j.jtct.2022.11.025","title":"A Multicenter, Retrospective Study Evaluating Clinical Outcomes of Ruxolitinib Therapy In Heavily Pretreated Chronic GVHD Patients With Steroid Failure","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Saskatchewan Cancer Agency; London Health Sciences Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Ruxolitinib; Prednisone; Internal medicine; Population; Hematopoietic stem cell transplantation; Transplantation; Clinical trial; Salvage therapy; Graft-versus-host disease; Refractory (planetary science); Retrospective cohort study; Adverse effect; Chemotherapy; Bone marrow","retraction":null,"screen_n_in":null,"score":{"opus":0.03390349540065966,"gpt":0.3283268832030288,"spread":0.2944233878023691,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006719594,0.0002333067,0.0005574887,0.0001720191,0.0001077856,0.00001278461,0.00008423308,0.0000618319,0.0003210634],"category_scores_gemma":[0.000006057181,0.0001832915,0.00009014405,0.0002731095,0.00006728011,0.0000814784,0.000005819815,0.0003104183,0.000001503473],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009499981,"about_ca_system_score_gemma":0.00009665525,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001072194,"about_ca_topic_score_gemma":0.00007256268,"domain_scores_codex":[0.9974093,0.0005720354,0.0007114724,0.0004221671,0.0006575413,0.0002275197],"domain_scores_gemma":[0.9992099,0.0001408115,0.0002174474,0.0002296647,0.0001207028,0.00008151822],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005067305,0.002316378,0.9725364,0.0001047503,0.0002716018,0.00004991518,0.01055171,0.00002909064,0.003710336,0.000009642854,7.94093e-7,0.005352039],"study_design_scores_gemma":[0.04684767,0.01000502,0.9371731,0.00006263861,0.000120755,0.000008658856,0.00171082,0.000166159,0.003720701,0.000007301509,0.000008188944,0.0001689836],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964446,0.000238049,0.0001975135,0.00006058358,0.00007890217,0.002772054,0.00007687897,0.00004025387,0.00009110083],"genre_scores_gemma":[0.9986451,0.0004581244,0.0002274695,0.00009738903,0.00001439179,0.0001658208,0.0003153248,0.00003812646,0.00003828786],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04178037,"threshold_uncertainty_score":0.7474409,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4280650301","doi":"10.1016/j.jtct.2022.05.018","title":"Geriatric Assessment Reveals Actionable Impairments in Hematopoietic Stem Cell Transplantation Candidates Age 18 to 80 Years","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Frailty in Older Adults","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Cancer Institute; National Institutes of Health; Baxter International; Belgian American Educational Foundation; Abbott Laboratories; National Institute on Aging; School of Medicine, Duke University; DSM; U.S. Department of Defense","keywords":"Medicine; Transplantation; Hematopoietic stem cell transplantation; Cognition; Internal medicine; Age limit; Stem cell; Cognitive impairment; Pediatrics; Oncology; Disease; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.01556008457581674,"gpt":0.2725051791446464,"spread":0.2569450945688296,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000277363,0.0001620114,0.0002400894,0.000261953,0.0001211933,0.00002823048,0.00007672048,0.00004912244,0.0005960034],"category_scores_gemma":[3.804844e-7,0.0001716805,0.00005553125,0.0003482402,0.00001641889,0.00009100621,0.00000577258,0.0001991969,0.00001501995],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001349172,"about_ca_system_score_gemma":0.00006432994,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001842026,"about_ca_topic_score_gemma":0.00002722201,"domain_scores_codex":[0.9985905,0.0001450928,0.000324416,0.0003094324,0.0003887136,0.0002418411],"domain_scores_gemma":[0.9995922,0.00004725436,0.00006631912,0.0001501548,0.00001940647,0.0001246802],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.005019732,0.001816801,0.08032469,0.002068484,0.0001819855,0.006192615,0.05774761,0.00207779,0.8212567,0.0001613562,0.001383368,0.0217689],"study_design_scores_gemma":[0.04385918,0.004240051,0.7857404,0.000423717,0.0004688531,0.001993197,0.007478188,0.0007965617,0.1441002,0.0005888076,0.008804232,0.001506603],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957937,0.0004157473,0.00129276,0.0003571975,0.0001491598,0.0009740512,0.00008746068,0.00005341759,0.0008764869],"genre_scores_gemma":[0.9940225,0.00204247,0.0004711961,0.0005401753,0.00002673918,0.0002036633,0.0005350946,0.00003011611,0.002128026],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7054157,"threshold_uncertainty_score":0.700093,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4306894665","doi":"10.1016/j.jtct.2022.10.013","title":"Rituximab Toxicity after Preemptive or Therapeutic Administration for Post-Transplant Lymphoproliferative Disorder","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"O'Brien Institute for Public Health, University of Calgary; Alberta Cancer Foundation","keywords":"Rituximab; Medicine; Neutropenia; Hypogammaglobulinemia; Post-transplant lymphoproliferative disorder; Internal medicine; Gastroenterology; Transplantation; Lymphoproliferative disorders; Immunosuppression; Immunology; Hematopoietic stem cell transplantation; Incidence (geometry); Toxicity; Lymphoma; Antibody","retraction":null,"screen_n_in":null,"score":{"opus":0.01986638566307865,"gpt":0.2731027629002081,"spread":0.2532363772371295,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002697367,0.0002801517,0.0003630318,0.0001274843,0.0003490607,0.00003726294,0.00007581506,0.000092543,0.0008808179],"category_scores_gemma":[0.000002523222,0.0002306906,0.0001352063,0.0001638604,0.00007576975,0.0001308475,0.000003717576,0.0001667856,0.000007132815],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005549859,"about_ca_system_score_gemma":0.0002021647,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002244683,"about_ca_topic_score_gemma":0.00005647049,"domain_scores_codex":[0.9983209,0.0001688348,0.0003951649,0.0004397669,0.000387871,0.000287488],"domain_scores_gemma":[0.9993334,0.0001723097,0.00009205005,0.0001747299,0.0001029527,0.0001245785],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.2902671,0.006521405,0.04459643,0.003765559,0.001572595,0.001336482,0.106756,0.0001179669,0.4953031,0.004693786,0.00005516894,0.04501448],"study_design_scores_gemma":[0.09020732,0.02129319,0.07998091,0.0004217854,0.002021227,0.004835229,0.009060017,0.003807624,0.7738112,0.001212652,0.01113717,0.002211679],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9388654,0.001074996,0.05554319,0.0009880859,0.0001361066,0.00232147,0.0007474174,0.00009705801,0.0002263377],"genre_scores_gemma":[0.9929719,0.001362263,0.0006982967,0.001601741,0.00005673316,0.001249473,0.001372018,0.00004954745,0.0006380376],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2785081,"threshold_uncertainty_score":0.9644339,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3210546731","doi":"10.1016/j.jtct.2021.10.013","title":"Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation","year":2021,"lang":"en","type":"review","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto; University of Calgary","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; Pharmacyclics; Sanofi Genzyme; Takeda Oncology; U.S. Public Health Service; Genentech; Health Resources and Services Administration; National Institutes of Health; MorphoSys; Daiichi-Sankyo; Seagen; Omeros Corporation; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; Kyowa Kirin Pharmaceutical Development; Medac; Jazz Pharmaceuticals; Cancer Moonshot; Medical College of Wisconsin; StemCyte; CareDx; Actinium Pharmaceuticals; Daiichi Sankyo Europe; National Cancer Institute; Gilead Sciences; Moonshot Research and Development Program; Sanofi; Karyopharm Therapeutics; Celgene; Novartis; GlaxoSmithKline; Amgen; Accenture; CSL Behring; Bristol-Myers Squibb; AstraZeneca; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Astellas Pharma US","keywords":"Medicine; Transplantation; Disease; Population; Systematic review; Intensive care medicine; Quality of life (healthcare); Internal medicine; MEDLINE","retraction":null,"screen_n_in":null,"score":{"opus":0.07421536235434607,"gpt":0.3167009603246929,"spread":0.2424855979703469,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002348408,0.0005296415,0.002065494,0.0001533122,0.0002073231,0.00004149433,0.0003289437,0.0002675754,0.000005467598],"category_scores_gemma":[0.00003601658,0.0003338149,0.0004194572,0.0004723037,0.0005447658,0.00008692834,0.00001799112,0.0005477422,1.640061e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001805553,"about_ca_system_score_gemma":0.00008656273,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008129284,"about_ca_topic_score_gemma":0.00007784883,"domain_scores_codex":[0.9935994,0.002632702,0.002108518,0.0006164073,0.0007326484,0.0003103494],"domain_scores_gemma":[0.9944973,0.003524726,0.001054614,0.0004980689,0.0003069032,0.0001183681],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0006062528,0.0005614947,0.02903647,0.9195732,0.001247836,0.00001937012,0.02171711,0.000002524121,0.02163979,0.0004548946,0.000004991256,0.005136014],"study_design_scores_gemma":[0.01738653,0.0003775859,0.03411938,0.9136842,0.01175367,0.0005092439,0.0005788829,0.00006998412,0.02042479,0.0001272366,0.000234166,0.0007342623],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.3105699,0.6815059,0.001006312,0.0002040384,0.0001388575,0.005578611,0.0009087031,0.00001260097,0.00007508734],"genre_scores_gemma":[0.3687254,0.6301785,0.0002313414,0.00007079529,0.00002034766,0.0001647501,0.0005545698,0.00004324728,0.00001097414],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.05815552,"threshold_uncertainty_score":0.9999114,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}